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SUMMARY 
The heart is the pump that irrigates the body to satisfy the nutrient and oxygen 
demands essential for keeping the organism alive. Understanding how the heart is 
formed and how its homeostasis is maintained in adulthood, is of great interest and 
can provide new insights on the etiology of cardiovascular diseases. In this doctoral 
thesis we studied the role of Meis1 and Meis2 transcription factors as possible 
regulators of cardiac development and homeostasis. 
We developed two mouse models for the conditional simultaneous deletion of Meis1 
and Meis2 in cardiomyocytes either during development or during adulthood. Analysis 
of Meis1 and Meis2 double deletion in the developing heart revealed cardiac 
malformations and perinatal death, together with impaired electrical impulse 
propagation through the ventricles. Adult mice with Meis1 and Meis2 loss of function 
in cardiomyocytes presented mild cardiac hypertrophy, polyploidization of 
mononucleated cardiomyocytes and impaired electrical impulse conduction through 
ventricular myocardium. 
The transcriptomic analysis of the mutants suggests that Meis1 and Meis2 transcription 
factors regulate calcium and sodium currents and GAP junction communication in 
developing and adult cardiomyocytes, which is in accordance with the electrical 
phenotypes observed. Moreover, the set of genes sensitive to Meis1 and Meis2 
deletion shows significant coincidence with those altered in mouse models of 
arrhythmogenic right ventricular cardiomyopathy, suggesting a role for these 
transcription factors in the pathogenesis of this disease. 
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RESUMEN 
El corazón es la bomba que alimenta el sistema circulatorio para satisfacer las 
necesidades de nutrientes y oxígeno del cuerpo. Entender cómo se regula el 
desarrollo del corazón y su homeostasis durante la vida adulta es de vital importancia 
para comprender la etiología de muchas enfermedades cardiovasculares. En esta 
tesis doctoral, estudiamos el papel de los factores de transcripción Meis1 y Meis2 
como posibles reguladores de estos procesos.  
Hemos generado dos modelos de ratón para el estudio de la función de Meis1 y Meis2 
en cardiomiocitos bien durante el desarrollo o durante la edad adulta. Tras la pérdida 
de función de Meis1 y Meis2 en cardiomiocitos durante el desarrollo, encontramos que 
los fetos mueren al nacer, presentando alteraciones morfológicas y defectos en la 
propagación del impulso eléctrico, necesario para el mantenimiento del ritmo de latido. 
Por otro lado, la deleción de estos factores en los cardiomiocitos del corazón adulto 
no es letal, pero conlleva la aparición de fibrosis, poliploidización de los cardiomiocitos 
mononucleados y cierta respuesta hipertrófica. Además, de forma similar a los 
observado en la deleción embrionaria, encontramos un empeoramiento de la 
conducción eléctrica con alargamiento del segmento QRS en el electrocardiograma.  
El análisis del transcriptoma de los mutantes indica que Meis1 y Meis2 podrían estar 
regulando las corrientes de sodio y calcio y la formación de uniones GAP, lo que 
correlaciona con las alteraciones encontradas en la propagación del impulso eléctrico 
del corazón en ambos modelos. Además, el conjunto de genes alterados por la falta 
de función de Meis presenta coincidencias significativas con el grupo de genes que se 
altera en un modelo de ratón de la enfermedad ARVC (“Arrhythmogenic Right 
Ventricular Cardiomyopathy”), sugiriendo que Meis1 y Meis2 podrían estar implicados 
en la patogénesis de esta cardiomiopatía. 
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INTRODUCTION 
The heart is a powerful pump that impulses the blood to irrigate all body organs. The 
mechanical action of the heart is provided by the cardiac muscle, which contracts 
during systole to pump the blood. After contraction, the muscle is dilated during 
diastole, creating negative pressure to get the blood back into the heart and pump it 
again. The adult mammalian heart is composed by two atria and two ventricles feeding 
two parallel circuits: the systemic circulation and the pulmonary circulation (FIG. 1). 
Atria and ventricles communicate through the atrioventricular valves. When the 
deoxygenated blood (blue in FIG. 1) from the systemic circulation enters the right 
atrium, there is an increase in pressure that leads to the opening of the tricuspid valve 
and the subsequent filling of the right ventricle. Then, the blood goes through the 
pulmonary valve to the lungs, gets oxygenated and comes back to the heart trough the 
left atrium, where the same process is repeated (pink in FIG. 1). In this case, the 
atrioventricular valve is called mitral or bicuspid and the oxygenated blood leaves the 
ventricle through the aortic valve. 
 
This process is essential for life, because it supplies a constant flow of nutrients and 
oxygen to all cells in the body. Thus, the heart is the first functional organ during 
embryonic development and any alteration of cardiac formation can lead to embryonic 
lethality or congenital heart defects (CHD). Currently, 30% of human pregnancies that 
do not come to term present cardiac malformations (Bruneau, 2008) and 3% of born 
Figure 1. Anatomy of the mammalian 
adult heart. Blue and pink colors 
represent deoxygenated and 
oxygenated blood respectively.  
RA, right atrium, RV, right ventricle, 
LA, left atrium, LV, left ventricle, Ao, 
aorta, P, pulmonary artery, svC and 
ivC, superior and inferior vena cava, 
Pv, pulmonary veins.  
  
 
14 
 
humans present some kind of CHD (Fahed et al., 2013; Parker et al., 2010). These 
percentages reflect how important the proper regulation of heart development is, in 
order to produce a functional organ throughout lifespan. 
Heart development 
Mouse gestation spans 19 days, which implies that developmental processes occur 
very rapidly. The mammalian heart starts to be formed very early in development as 
the first cardiac progenitors arise at E6.5 from the pluripotent cells of the epiblast. 
These epiblast-derived cells migrate anteriorly from the primitive streak and form the 
cardiac mesoderm at both sides of the ventral midline (Lawson et al., 1991; Tam & 
Behringer, 1997). This pool of cells expresses Mesp1 (Mesoderm Posterior 1) which 
is a key regulator for cardiac specification (Saga et al., 1999; Saga et al., 2000). One 
day later, Mesp1+ cells migrate anteriorly and fuse medially, forming the cardiac 
crescent (CC) (FIG. 2). At this stage, many transcription factors necessary for 
cardiogenesis are activated: Gata4, Nkx2.5, Mef2c, Hand1/2 and Tbx5 (Martin-Puig et 
al, 2008; Bondue & Blanpain, 2010). The CC is a peristaltic pump located under the 
growing head folds (Ivanovitch et al, 2017). It is composed of an inner layer of 
endocardium and an outer layer of myocardium (Vincent & Buckingham, 2010).  The 
progenitors that give rise to the CC are known as First Heart Field (FHF) (Kelly, 2012; 
Später et al., 2013).  
As the CC grows, cells move to form a transversal hemi-tube which later adopts a more 
spherical shape and is still dorsally dorsally open (Ivanovitch et al, 2017). The 
endoderm serves as a transient dorsal wall and the hemi-tube is progressively closed 
giving rise to the primitive heart tube (Kelly et al, 2014; Evans et al, 2010). The primitive 
HT has the same two layers as the CC, but venous and arterial poles are now present.  
The future left ventricle and part of the atria arise from the primitive HT (Zaffran et al, 
2004). There is another pool of cardiac progenitors which remains undifferentiated and 
starts differentiation after the linear HT is formed. This pool is called Second Heart 
Field (SHF). Fgf10 and Isl1 are some of the factors characteristic of this region. The 
SHF is located dorso-medially to the CC in the region of the splanchnic mesoderm and 
progenitors are incorporated into the HT trough the venous and arterial poles, 
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contributing to HT elongation (Kelly et al, 2001; Mjaatvedt et al, 2001; Waldo et al, 
2001; Cai et al, 2003). SHF progenitors will form the right ventricle, the outflow tract 
and part of the atria (Zaffran et al, 2004). As the HT elongates, it undergoes rightward 
looping and chambers start to be specified (E8.5) (FIG. 2). Outflow tract (OFT) and 
forming right and left ventricles can be already identified at this point. The connection 
between atria and ventricles is made by the atrioventricular canal. At E10.5 outflow 
and inflow tracts align with the ventricles reaching their definitive location (Watanabe 
& Buckingham, 2010).  
Later on, the developing heart initiates an expansion process by proliferation at specific  
regions of the outer curvature of the heart tube, which generates the chambers, 
according to the ballooning model (Christoffels et al, 2000). Between E9.5 and E14.5 
there is not only growth but also complete chamber specification and morphogenesis. 
After looping, CMs continue dividing and some of the newly formed CMs will protrude 
towards the endocardium. This protruding CMs slow their proliferative rate and form 
the trabeculae, which are transient ridge-like structures that protrude towards the 
lumen of the chambers. The initial layer of myocardium is now called compact layer 
and will continue proliferating and increasing in thickness (Blausen et al, 1990; 
Sedmera et al, 2000, 2003; Staudt et al, 2014). At E14.5 all chambers are established 
and further proliferation and maturation will occur until the first postnatal days (FIG. 2). 
The increase in compact layer thickness is accompanied by the development of the 
coronary system that serves to irrigate the myocardium, which satisfies the high 
metabolic rate of cardiomyocytes. Ventricular chamber maturation involves trabecular 
remodeling and compaction. During compaction, the trabecules become thicker and 
coalesce until the spaces between them form capillaries (Wessels & Sedmera, 2003). 
By the end of gestation, right and left ventricles are completely separated by the 
septum. However, the atrial septum does not close until around postnatal day 7 (P7) 
(Cole-Jeffrey et al, 2012).  
The FHF and SHF are the main sources of progenitors during cardiogenesis, but there 
are other pools of progenitor which are essential for heart formation (Vincent & 
Buckingham, 2010).  
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The epicardium is the outer-most layer of the heart and it derives from the 
proepicardium. The proepicardium is a pool of cells that derive from the coelomic 
epithelium located in the dorsal pericardial wall. PE cells expressed different markers, 
among which, Tbx18 and Wt1 are the best established. From E9.5 to approximately 
E14.5, cells detach from the PE and cover the heart progressively by migration and 
proliferation, (FIG. 2) (Viragh & Challice, 1981) (Wu et al, 2010). 
 
Moreover, epicardial cells undergo epithelial-mesenchymal transition to invade the 
myocardium and there differentiate into fibroblasts, vascular smooth muscle cells and 
part of the vascular endothelial cells (Wessels & Pérez-Pomares, 2004). It has been 
proposed they might also contribute to CMs but this is still a debate and remains to be 
elucidated (Krainock et al, 2016). 
Another source of progenitors is the cardiac neural crest (CNC). This progenitor 
population arises from the dorsal neural tube and migrates towards the heart around 
mid-gestation (FIG. 2) (Lee et al, 1995; Jiang et al, 2000; Brown & Baldwin, 2006). It 
has been shown that CNC cells contribute to the smooth muscle cells from the arterial 
Figure 2. Embryonic heart development in mouse. Schematic representation of key 
phases in murine cardiac development. From left to right, cardiac crescent (CC) at E7.5 
with f irst heart f ield (FHF, in red) and second heart f ield progenitors (SHF, in green).  
The heart tube (HT) is formed (E8.0) and elongates as SHF progenitors incorporate to 
the tube through the arterial and venous poles (E9.5). Between E8.0 and E9.5,the heart 
loops and chambers are specif ied. The right ventricle (RV), outflow tract (OFT) and 
inf low tract (IFT) are represented in green as SHF derivatives, while left ventricle (LV) 
and part of the atria (A) are in red, as FHF derivatives. The proepicardium (PE) is 
represented in yellow. Cardiac neural crest cells (CNC) are incorporated into the OFT 
region. The last draw represent an E14.5 embryonic heart with the 4 chambers and great 
vessels, aorta and pulmonary arteries (Ao;P) differentiated. Cartoon adapted from 
Stéphane D. Vincent and Margaret E. Buckingham, 2010.  
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pole of the heart and their incorporation to this structure is important for OFT 
remodeling and division into aorta and pulmonary arteries (Keyte et al, 2014). 
Postnatal heart maturation 
During the first week of life, the heart still undergoes important genetic and metabolic 
changes. In the last decades, many studies have focused on the description of those 
changes and their regulation.  
After birth, the CMs proliferative rate is dramatically decreased in mice and humans 
(FIG. 3) (Soonpaa et al, 1996; Mollova et al, 2013). However, in a few days, the size 
of the heart is duplicated due to a hypertrophic process of the CMs (Li et al, 1996). 
This hypertrophy is linked to an increase in CM ploidy that results predominantly in 
binucleation of CMs in mice and nuclear polyploidization in humans (FIG. 3) 
(Bergmann et al, 2015). Whereas developing CMs are mononucleated, around P21 
85-90% of CMs are binucleated in mice (Soonpaa et al, 1996; Walsh et al, 2010). In 
general, genes promoting CM cell cycle are strongly downregulated while genes 
inhibiting the cell cycle are upregulated during this process (Engel et al, 2005; Quaife-
Ryan et al, 2017). The reasons for these changes are still under study. It has been 
proposed, that the increase in oxygen levels after birth might lead to the activation of 
the oxidative stress damage response and the subsequent cell cycle arrest (Puente et 
al, 2014; Kimura et al, 2014). 
In addition, it has been recently discovered that the neonatal mouse heart presents the 
capability to regenerate after injury during the 3-4 first postnatal days, although at P7 
this ability is lost (Porrello et al, 2011). This was a very encouraging finding because it 
opened the possibility of activating adult CM proliferation to stimulate cardiac injury 
repair. Many efforts have been concentrated on understanding the molecular 
mechanisms underlying CMs cell cycle arrest (Tzahor & Poss, 2017). Activation of 
Hippo signaling is one of the mechanisms shown to inhibit postnatal CMs proliferation 
(Heallen et al, 2011; von Gise et al, 2012) and administration or upregulation of 
extracellular matrix proteins has been shown to modify the regenerative capacity of the 
heart (D’Uva et al, 2015; Bassat et al, 2017). Recently, Meis1 was identified as 
negative regulator of postnatal CMs cell cycle (Mahmoud et al, 2013). More studies in 
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this field are still needed to achieve adult CM regeneration, although recent advances 
in the pig model are encouraging (Gabisonia et al, 2019). 
.  
The cardiac conduction system  
The formation of a proper functional heart requires not only the accomplishment of 
complex and varied morphogenetic processes, but also the establishment of the 
adequate cardiac rhythm.  In mammals, the nervous system and hormones regulate 
the cardiac rate to adapt it to the needs of body’s cells for oxygen and nutrients. 
However, there are specialized CMs with the capability of automaticity in electrical 
pacing, known as the pace-maker cells, which, in the absence of extrinsic influences, 
can maintain constant basal heart rhythm (Gordan et al, 2015). These CMs present 
few sarcomeres, less mitochondria and T tubules and enriched glycogen content 
(Virágh S, 1977; Myers & Fishman, 2003). 
Heartbeats originate as a spreadable rapid rise and fall of voltage across the cellular 
membrane which is called action potential (AP). The AP is generated in the sinoatrial 
node (SAN) and spreads through a system of specialized CMs known as the Cardiac 
Conduction System (CCS). All CCS CMs can generate action potentials, although the 
SAN has the fastest rate of spontaneous depolarization and, therefore, acquires the 
role of pacemaker. The SAN is located at the dorsal part of the right atrium, close to 
the superior cava vein entrance (FIG. 4A). From the SAN, the impulse spreads 
throughout the atria inducing their contraction. Then, the AP reaches the atrio-
ventricular node (AVN), where it suffers a delay before entering the His Bundle (HB) at 
the base of the ventricles (FIG. 4A). The delay created by the AVN is essential to allow 
Figure 3. Postnatal cardiomyocyte maturation. Changes between P0 and P7 in 
mammalian cardiomyocytes. Cell cycle is arrested and the regenerative capacity is lost, 
while the binucleation and polyploidization become predominant in cardiomyocytes.  
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blood flow from atria to fill the ventricles during atrial systole and before ventricular 
systole. The atrial and ventricular myocardium are electrically isolated from each other 
by the annulus fibrosus and central fibrous body. The HB is the only CCS element that 
crosses this insulation, running through the crest of the ventricular septum and 
transmitting the electrical impulse from atria to ventricles.  
 
Two branches arise from the HB, right and left bundle brunches (RBB; LBB) located at 
either side of the interventricular septum. BBs prolong from the top of the septum 
towards the apex and connect to the Purkinje Fiber network (PF) at the tips (FIG. 4A). 
Then, the AP is rapidly transmitted to the whole ventricles, from apex to base, leading 
to subsequent ventricular contraction and ejection of blood through the great arteries. 
PFs are distributed throughout the ventricular walls and they are mainly located in a 
sub-endocardial position (Van Weerd & Christoffels, 2016). The ventricular conduction 
system (VCS), composed of the HB, the BBs and the PFs is electrically isolated from 
the working myocardium by connective tissue, so that the electrical impulse only 
reaches the working myocardium through the Purkinje-Myocyte junctions. This 
Figure 4. Cardiac conduction system and electrocardiogram interpretation. A. 
Adult heart representat ion with cardiac conduction system anatomy in red. From left 
to right, yellow areas represent the sequence of activated regions upon electrical 
impulse generat ion in the sinoatrial node (SAN). Atrioventricular node (AVN), Hiss 
Bundle (HB), right and left Bundle Brunches (BBs) and Purkinje Fibers (PFs) . B. 
Example of human electrocardiogram with highlighted areas in yellow that correspond 
to the phases represented in (A).  
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ensures the proper timing and the apex-to-base contraction of the ventricles for 
efficient blood pumping (Munshi, 2012).  
Electrophysiology of the adult heart 
The adequate function of the CCS is essential for life. Perturbations of heart rhythm 
lead to an important proportion of morbidity and mortality in the human population. 
Nowadays, the overall prevalence of arrhythmias is approximately 3.4% (Andersson et 
al, 2013; Zoni-Berisso et al, 2014; Clauss et al, 2019), however, the pathophysiology 
of arrhythmias is complex and not completely understood.  
The electrocardiogram (ECG) is a diagnostic tool that allows the study in detail of CCS 
function. It is widely used in humans and also in animal experiments. It consists on the 
measurement of voltage versus time, which generates a pattern with several waves 
and isoelectric segments, each one reporting the activity of a particular part of CCS 
and working myocardium electrical activity (FIG. 4B). A proper interpretation of the 
electrocardiogram is essential for a good description of CCS function. The human ECG 
was described for the first time in 1895 by Einthoven  and eighty-three years later, in 
1968, the first description of the mouse ECG was published (Fye, 1994; Goldbarg et 
al, 1968). Comprehension of both ECGs is of crucial importance for the extrapolation 
of the results in mouse models to human health. 
Before ECG interpretation, it is necessary to explain the molecular basis of the action 
potential. The AP is produced by the interchange of ions between the cell and the 
intercellular space (FIG. 5A). AP shape varies between species and also between 
different regions of the heart. In general, the resting voltage potential across the CM 
plasma membrane is usually -90mV with higher concentrations of Na+ outside the cell 
and of K+ inside. When the action potential is generated, fast sodium channels are 
opened creating an inward Na+ current that rapidly increases voltage across the 
plasma membrane (sarcolemma) to values of +10mV (FIG. 5A, B). This phenomenon 
is known as depolarization. The returning to the resting membrane voltage is called 
repolarization and is achieved by outward K+ current to the intercellular space (FIG. 
5A, B). In human CMs, there is and intermediate phase, after the beginning of 
repolarization, called plateau phase. In this phase, calcium channels are opened, so 
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that Ca2+ enters the cell while K+ outward current occurs, keeping voltage on values of 
about 0mV before complete repolarization (FIG. 5A, B) (Nerbonne & Kass, 2005). 
Transient hyperpolarization is normally observed in human CMs due to the potassium 
outward current that brings the voltage to more negative values than in the resting 
phase. These differences in AP between mice and humans creates different ECG 
patterns. 
 
Figure 5. Electrophysiology of human and murine ventricular cardiomyocytes. 
A. Schematic representation of ion exchange during AP phases in CMs. Brackets 
indicate the plateau phase that is exclusive of human CMs. B. Action potential shapes 
in human and mouse ventricular CMs. C. The ECG prof ile in human and murine hearts 
with indication of each wave. Colors indicate the phases of AP: red, depolarization, 
green, repolarization and blue, plateau phase.  
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The time between the end of P wave and the initiation of Q wave corresponds to the 
delay between atrial and ventricular conduction (FIG. 4B, 5C). Prolongation of this 
segment might indicate an atrio-ventricular conduction delay or block. Then, the QRS 
complex appears, reflecting ventricular depolarization, with a morphology that differs 
between mice and humans (FIG. 4B, 5C). 
In mice, ventricular repolarization occurs immediately after the QRS, however, in 
humans, ventricular repolarization takes a longer time and generates the T wave after 
and isoelectric segment (FIG. 4B, 5C) (Boukens et al, 2014). In mice, the T wave 
voltage is negative and ends when it reaches the isoelectric line (FIG. 5C) (Boukens 
et al, 2014). The atrial repolarization wave is not seen probably because is hidden by 
the QRS complex.  
Molecular and cellular bases of cardiac conduction 
Synchronous impulse propagation and contraction requires proper excitation-
contraction coupling. Calcium signaling is a key regulator of this process allowing to 
pair depolarization with mechanical contraction. When electrical impulse reaches 
working CMs and depolarization starts, L-type Voltage-operated Ca2+ channels 
(VOCC) (Cav1.2)  are opened (Fearnley et al, 2011). Ca2+ flows into a restricted space 
between sarcolemma and sarcoplasmic reticulum (SR) known as “dyadic cleft”. Ca2+ 
accumulation in this micro domain induces opening of RyR2 (Type 2 Ryanodine 
Receptor) located in the SR and produces a Ca2+ release signal known as “Ca2+ spark” 
in a processed called “calcium-induced calcium release” (CICR) (FIG. 6). Ca2+ ions 
diffuse to engage the Troponin C, which is the Ca2+ binding component of the 
contractile machinery, and contraction occurs. After activation of contractile units, Ca2+ 
is rapidly removed from the cytosol causing relaxation and preparing the cell for the 
next action potential (Shannon and Bers, 2004). The main mechanisms for calcium 
efflux from the cytosol is the Ca2+ ATPase2 (SERCA2) pump located at the SR (FIG. 
6). There are also sodium/calcium exchanger channels (NCX) in the sarcolemma that 
contribute to this process in a smaller percentage (FIG. 6) (Fearnley et al, 2011). It has 
been shown this system has high adaptability robustness, since SERCA2 cardiac-
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specific knockout mice showed minimal cardiac dysfunction due to a compensatory 
increase in NCX activity (Andersson et al, 2009).  
 
The contractile and electrical forces spread readily between adjacent CMs thank to the 
intercalated disc (ID). IDs are located at the ends of the rod shaped CMs and are 
composed of desmosomes (intercellular adhesion), fascia adherens (transmission of 
contractile forces) and Gap junctions (AP propagation) (FIG. 7) (Estigoy et al, 2009). It 
has recently been observed that these elements are in close interaction, so defects in 
the structural part of IDs can affect excitability of the cells and vice versa (Moncayo-
Arlandi & Brugada, 2017).  
In vertebrates, gap junctions are formed by connexins, which are trans-membrane 
proteins that enable the direct cytoplasmic exchange of ions and low molecular weight 
metabolites between adjacent cells (Nielsen et al, 2012). In the adult murine heart, 
there are different connexin isoforms and Cx43, Cx40, Cx45 and Cx30.2 are the 
predominant ones (Davis et al, 1994; Jansen et al, 2010). Cx43 is the major isoform, 
expressed in both atrial and ventricular myocardium. Cx40 is present in the atria, AVN 
and VCS (Beyer et al., 1987; Davis et al., 1994). Cx45 and Cx30.2 are less studied 
and their expression is more restricted to the CCS (Coppen et al, 1999; Kreuzberg et 
al, 2009, 2005). Furthermore, sodium channels, like Nav1.5, essential for electrical 
impulse conduction, concentrate at the intercalated disc too (FIG. 7) (Dhar Malhotra et 
al, 2001).  
Figure 6. Calcium-Induced Calcium 
Release. (1) Extracellular calcium enters 
cytosol through L-type Calcium Channels 
(LTCC) inducing Calcium release from the 
sarcoplasmic reticulum (SR) by RyR2 (2).  
Increased cytosolic calcium concentration 
allows contraction of the sarcomeres (3). 
Init ial calcium levels are recovered via 
SERCA2 and NCX, which recruit calcium 
in the SR and extracellular space, 
respectively (4 and 5).  
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Disorganized intercalated discs can lead to several cardiac diseases. One example is 
the arrhythmogenic right ventricular cardiomyopathy (ARVC), that arises from 
mutations in structural proteins of the desmosomes and leads to fibrosis, reduced and 
mislocalized Cx43 and arrhythmias that can lead to sudden cardiac death (Gard et al, 
2005; Cerrone et al, 2012a). Brugada Syndrome, is considered a channelopathy, 
mainly related with mutations in Scn5a (Nav1.5), however, mutations in proteins of the 
desmosomes can also affect Scn5a expression and reproduce several Brugada 
Syndrome features (Moncayo-Arlandi & Brugada, 2017). These data indicate that the 
structural and the excitability components of the IDs do interact with each other.  
Cardiac Conduction System development 
Genetic and environmental factors are both contributing to the development of 
arrhythmias. The comprehension of CCS embryonic development can help to elucidate 
the genetic origin of some types of arrhythmias. 
In the mouse, as mentioned above, the CC is already a beating structure. Those beats 
are automatically generated by the newly formed CMs derived from the FHF. At this 
stage, CMs are poorly differentiated, presenting underdeveloped sarcomeres and SR, 
which resemble adult conducting CMs. Markers that are later exclusive for CCS, such 
as Hcn4 and Cx40 are expressed in the myocardial layer of the HT (Mommersteeg et 
al; Später et al, 2013). At E8.0, when the HT is formed, the dominant automaticity is 
located in the venous pole and all cells conduct similarly, so that blood is pumped 
towards the arterial pole or OFT in a peristaltic mode (FIG. 8). The transcription factor 
Nxk2.5 is initially expressed in the CC and SHF precursors, although later on, when 
the heart elongates and starts looping, Tbx18 is the predominant marker in the venous 
pole, where pacemaker CMs are formed (Christoffels et al, 2006; Mommersteeg et al; 
Figure 7. Intercalated disc 
composition. Draw of the different 
structures that can be found in 
intercalated discs separated by 
function: adhesion and excitabil ity.  
Orange is cytosol and pink 
extracellular space between two 
couple CMs.   
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Wiese et al, 2009). The SAN can be anatomically distinguished for first time at E11.5 
(Challice & Virágh, 1980).  
The atrioventricular canal (AVC) is the structure of the primitive tube that separates 
atria and ventricles and gives rise to the atrio-ventricular ring and AVN (FIG. 8). The 
AVC comes from Tbx2+ cells at the IFT of the HT. Around E9, the AVC expresses 
Bmp2, Tbx2 and Tbx3 (Singh et al, 2012). This combination of TFs represses the 
expression of markers for chamber myocardium and keeps Cx30.2, which is important 
for the slow conduction phenotype of the AVN. From E12.5 onwards the annulus 
fibrosus insulates atria from ventricles and Tbx3+ cells form the AVN. It has been 
described that Tbx5 and Gata4 also contribute to the slow conduction velocity found in 
the AVN (Munshi et al, 2009). In contrast, the ventricular conduction system is fast 
conducting due to expression of Cx40 and Scn5a. The HB forms from the arterial pole 
of the HT and the timing is similar to that of the AVN (Mohan et al, 2017) (FIG. 8). 
However, the BBs and the PFs are specified later in development, around E15.5. BBs 
come from sub-endocardial CMs located in the trabecules of the septum and PFs from 
the trabecules of the ventricular chambers, being SHF-derived in the RV and FHF-
derived in the LV (Christoffels & Moorman, 2009; van Eif et al, 2018). The origin of the 
VCS has been long debated and still some aspects of it remained obscure. Clonal 
analysis has shown that VCS share a common progenitor with surrounding working 
CMs and after specification there are limited rounds of proliferation (biphasic model) 
(Miquerol et al, 2010). However, it has been suggested that CNC and epicardial 
derived cells can contribute to the VCS, although there are not yet definitive 
conclusions about this possibility (Nakamura et al, 2006; Aanhaanen et al, 2010). 
Nevertheless, it is clear that different elements of the CCS derive from different 
progenitor pools of the FHF and SHF, although in the adult heart, they are integrated 
in a single conduction system (Miquerol et al, 2011). 
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Meis transcription factors 
As described, cardiogenesis is a complex process that requires to be tightly regulated. 
Transcription factors (TF) play an important role in the regulation of embryonic 
development, since they possess the capability to bind DNA and control the expression 
of a subset of genes. There are TFs whose function in heart development has been 
studied for decades, but many others have been recently discovered. 
Meis TFs belong to the TALE family (Three Aminoacid Loop Extension) and are highly 
conserved among species at the molecular and functional level (Longobardi et al, 
2014a). Meis1 (myeloid ecotropic viral integration site 1 ) was the first gene of the 
family to be identified (Moskow et al, 1995). In mammals, two more genes with high 
homology were identified; Meis2 and Meis3 (Nakamura et al, 1996; Oulad-Abdelghani 
et al, 1997). Except in the head, the expression patterns of Meis1 and Meis2 in 
embryos are highly similar and both genes encode very similar proteins, which 
suggests they might have redundant functions. In contrast, Meis3 expression is mainly 
restricted to the hindbrain, although it can be also detected in the heart, spleen and 
lung at later stages (Nakamura et al, 1996). A Meis3 knockout mouse has not been 
generated so very little is known about Meis3 functions in mammalian development.  
Figure 8. Cardiac conduction system development. E8.0 heart tube (HT), E12.5 and 
adult hearts. Each color represents a different part of the adult CCS and the location 
of their progenitors during cardiac development.  
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Meis1 is expressed in the neural tube, the eye, the ear primordium, gut, cardiac 
chambers, lung, paraxial mesoderm (Hisa et al, 2004; González-Lázaro et al, 2014) 
and proximal domain of the forming limb (Mercader et al, 1999). Meis2 expression 
pattern overlaps with that of Meis1 in many of the areas described above. However, 
Meis2 is not expressed in the eye, while it does so in midbrain, forebrain and kidneys, 
where Meis1 has not been detected (Oulad-Abdelghani et al, 1997; Cecconi et al, 
1997; Mercader et al, 1999). 
In addition, Meis TFs function as cofactors of other TFs, such as Pbx, Prep or Hox 
factors (Mann & Affolter, 1998; Ryoo et al, 1999). They can form dimers or trimers, 
modifying the cofactors’ affinity and selectivity for DNA-binding sites. Thus, there is 
increased difficulty in understanding Meis TFs function, because it varies depending 
on the context. 
Meis1 knockout mice die around E14.5 due to failing hematopoiesis (Hisa et al, 2004; 
Azcoitia et al, 2005). Defects in these mutant embryos also present eye and fetal liver 
hypoplasia and interventricular septal defects in the heart (Hisa et al, 2004; Azcoitia et 
al, 2005; Stankunas et al, 2008; González-Lázaro et al, 2014). It has been reported 
that Meis2 knockout mice also die around E14.5, presenting hemorrhages and 
Persistent Truncus Arteriosus (PTA) (Machon et al, 2015). This defect derives from the 
failure in separating the aortic and pulmonary trunks, and is a relatively common CHD 
in humans.  
Meis1 functions have been also studied in adult organisms, where it is important for 
the maintenance of hematopoietic stem cell quiescence in the hematopoietic niche 
(Simsek et al, 2014; Unnisa et al, 2012). It plays a key role in the development of 
leukemia and other cancer diseases (Wong et al, 2007; Zha et al, 2014) and it is 
associated with the Restless Legs Syndrome in humans (Spieler et al, 2014). 
Moreover, regarding the heart, it has been shown that Meis1 is important for the cell 
cycle arrest of postnatal CMs in mice (Mahmoud et al, 2013) while Meis1 genetic 
variants are associated with PR elongation in humans, suggesting a role in the CCS 
function (Pfeufer et al, 2010; Smith et al, 2011a). In addition, sporadic germline 
heterozygous Meis2 mutations in humans lead to palatal defects, intellectual disability 
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and congenital heart defects, mainly affecting the interventricular septum and OFT 
positioning (Louw et al, 2015; Verheije et al, 2019; Giliberti et al, 2019). 
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OBJECTIVES 
We consider there are enough evidences suggests Meis1 and Meis2 play a role in 
cardiomyocytes of the developing and adult heart but they have not been explored in 
detail yet. Moreover, understanding Meis1 and Meis2 function in the heart will generate 
new knowledge in the cardiovascular field that might be relevant for the understanding 
of certain human diseases.  
Thus, the main goal of this thesis is to study the role of Meis1 and Meis2 transcription 
factors in the context of cardiac development and adult heart homeostasis. 
To achieve this goal, we propose the following concrete objectives: 
 
1- Describe the expression pattern of Meis1 and Meis2 in the developing and adult 
heart. 
 
2- Generate mouse models for the cardiomyocyte-specific constitutive and 
inducible double deletion of Meis1 and Meis2. 
 
3- Characterize the phenotype generated upon Meis1 and Meis2 constitutive and 
inducible loss of function in cardiomyocytes. 
 
4- Describe molecular determinants of Meis function in cardiomyocytes. 
 
5- Identify potential direct targets of Meis1 and Meis2 in cardiomyocytes. 
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MATERIALS & METHODS 
ANIMAL PROCEDURES 
Mouse lines 
All animals in this project were handled following CNIC Ethics Committee, Spanish 
laws and the EU Directive 2010/63/EU. All the experiments were approved by CNIC 
and Universidad Autónoma de Madrid Committees for “Ética y Bienestar Animal” and 
the area of “Protección Animal” of Comunidad de Madrid with reference PROEX 
220/15. In this study mice were maintained on a mixed genetic background. 
To study the expression of Meis1 we took advantage of two knock-in mouse lines 
previously generated in the laboratory: Meis1-ECFP and Meis1-CreER (González-
Lázaro et al., 2014). Meis1-CreER was crossed with R26RTdTomato (Madisen et al, 
2010) line containing a STOP cassette flanked with LoxP sites, followed by Tomato 
fluorescence protein, in the R26 locus. Upon Cre recombination STOP cassette is 
removed and Tomato fluorescence protein is expressed in the recombined cell and its 
offspring. CreER is only active for recombination in the presence of tamoxifen. 
Tamoxifen was administered orally to adult mice (1mg/day for 5 consecutive days). 
Hearts were harvested two days after tamoxifen injection. 
To understand the function of Meis1 and Meis2 in developing and adult CMs, we 
generated two models that allowed us to simultaneously delete both genes specifically 
in CMs. To generate a Meis1flox/flox; Meis2flox/flox mouse line, we combined a Meis1-flox 
(Unnisa et al, 2012) gently given by Dr. Sadek and a Meis2-flox allele generated in the 
laboratory of Miguel Torres (Roselló and Giovinazzo, unpublished). Loxp sites flank 
exon 8 in Meis1 and exon 3 in Meis2. Upon recombination, Meis1 loses the 
homeodomain coding region, essential for Meis1 activity and Meis2 does not produce 
any protein.  For the induction of LoxP recombination, we used two transgenic Cre 
lines specific for CMs, α-MHC-Cre (Agah et al, 1997) and α-MHC-MerCreMer, 
inducible by tamoxifen (Sohal et al, 2001).  
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We crossed Meis1flox/flox; Meis2flox/flox females with Meis1flox/wt; Meis2flox/flox; α-MHC-
Cretg/wt males in order to obtain 25% of embryos with Meis1 and Meis2 double 
homozygous deletion, Meis1flox/flox; Meis2flox/flox; α-MHC-Cretg/wt (dKO), 25% 
Meis1flox/flox; Meis2flox/flox; α-MHC-Crewt/wt and 25% Meis1flox/wt; Meis2flox/flox; α-MHC-
Crewt/wt (both used as control) and 25% of Meis1flox/wt; Meis2flox/flox; α-MHC-Cretg/wt 
(M1Het;M2KO).  
In the case of Meis1 and Meis2 deletion in adult CMs, we continued using the same 
Meis1flox/flox; Meis2flox/flox mice but crossing them with Meis1flox/flox; Meis2flox/flox; α-MHC-
MerCreMertg/wt to obtain 50% of Meis1flox/flox; Meis2flox/flox; α-MHC-MerCreMertg/wt 
(inducible-dKO or idKO) and 50% of Meis1flox/flox; Meis2flox/flox; α-MHC-MerCreMerwt/wt 
(Control). As an extra control for possible Cre toxicity we used α-MHC-MerCreMertg/wt 
(CRE) compared to their wild type (WT) littermates. Tamoxifen was administered 
through oral-gavage (1mg/day for 5 consecutive days) to mice around 10 weeks of 
age. All experimental groups of this model were given tamoxifen.  
Animals were genotyped by PCR following protocols detailed in the publication of each 
line. In the case of Meis2flox/flox, here are explained the primers and program used: 
Fw: CAA GGA CGC AAT CTA TGG GTA 
Rv: TGC AGA AAA CTT TCC TCT TAA TCA 
PCR program: (3´95º, 35x (30´´95º, 30´´51º, 1´30´´72º) 7´72º and 4º) 
Tamoxifen preparation 
200mg of tamoxifen (Sigma-T5648-1G) were dissolved in 20ml of corn oil (Sigma-
C8267) for a final concentration of 10mg/ml. The solution was sonicated for 1 hour in 
ice with ultrasonic homogenizer (Bandelin) and then aliquoted to store at 4ºC. When 
the stock solution preparation was older than 1 week, the aliquots were re-sonicated 
for 15 min before use. 100ul were given by oral-gavage to the mice per day, during 5 
days. 
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Embryo harvest 
Mice were mated in the afternoon and females were checked in the morning for the 
presence of vaginal plug. The stage of the embryos was defined by the day when the 
plug was observed, considering at noon of that day embryonic day 0.5 (E0.5). 
Pregnancy was always checked again before sacrifice, to avoid false positives. 
Pregnant females were euthanized by CO2 inhalation and the uterus was extracted 
through an incision of the abdominal cavity and transferred to PBS. Then, in a petri 
dish containing PBS, the muscular layer of the uterus was removed with forceps. For 
embryos at E13.5 or younger, a piece of the yolk sac was collected for genotyping and 
from E14.5 onwards the tip of the tail was used instead. After removing the yolk sac 
and amnion, embryos were decapitated and the thorax was opened to collect the heart. 
Hearts were quickly wash in PBS and fixed in paraformaldehyde (PFA) (Merck) 2% in 
PBS overnight at 4ºC. 
Adult mouse sacrifice 
Heparin (ROVI 1000UL/mL) was injected intraperitoneal in mice (200µL), 30 minutes 
before sacrifice to improve blood removal. Adult mice were sacrificed at different 
experimental points by CO2 inhalation and hearts were harvested by opening the 
thorax with scissors and forceps. Hearts were place in a petri dish with a KCl 30mM 
solution to stop beating in the phase of diastole. After removing lungs and thymus, 
hearts were weighted and placed in another petri dish with PBS for cannulation. A 5ml 
syringe (Beckton Dickinson) with a blunt needle was introduced in the left ventricle 
through the aorta and PBS was infused slowly until blood was removed. Then, hearts 
were fixed in PFA 2% in PBS 24 hours at 4ºC. The left posterior leg of every mice was 
cut, and skin and muscle removed, to measure tibia length with a caliber. 
BrdU treatment 
Adult mice were treated with BrdU (5-Bromo-2’-desoxyuridine; Merck B5002) dissolved 
at 0.5mg/mL in drinking water for 3 weeks. The treatment started one week after 
tamoxifen administration.  
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TISSUE PROCESSING 
Cryo and paraffin-sectioning 
After fixation, tissues were washed several times in PBS and cryopreserved with 15% 
sucrose overnight at 4ºC. Then, tissues were incubated in a solution with 15% sucrose 
and 7.5% gelatin in PBS at 37ºC for at least 4 hours, changing the solution and 
agitating occasionally. Gelatin blocks were prepared in a P6 dish at room temperature 
for gelatin solidification. Blocks were cooled down at 4ºC and frozen in isopentane at -
80ºC for 1 minute and kept stored at -80ºC until cryo-sectioning. 8 µm-thick sections 
were obtained using a Leica CM1950 automated Cryostat and stored at -20ºC. 
If the objective was to do paraffin sections, tissues were directly washed with 70% 
ethanol after fixation. Then, samples were incubated in different solutions at room 
temperature with increasing percentage of ethanol, until incubation with xilol. Samples 
were embedded in paraffin at 65ºC and after orientation, left at 4ºC to solidify. The 
dehydration process was usually done in a Thermo Excelsior SA processor at the 
Histopathology Unit at CNIC. Paraffin blocks were cut at 4 µm (10 µm for in situ 
hybridization) using a Leica RM2245 semi-automatic microtome. Sections were stored 
at 4ºC. 
In both cases sections were collected on Superfrost+ slides (Fisherbrand). 
IN SITU HYBRIDIZATION ON SECTIONS 
Paraffin sections were rehydrated from xilol to PBS passing through sterile solutions 
with decreasing concentrations of ethanol. Sections were digested with proteinase K 
(10µg/ml) at 37ºC for 10 minutes. Riboprobe hybridization was performed at 65ºC 
overnight. The next day, sections were washed and incubated with anti-DIG antibody 
at 4ºC overnight. Then, sections were developed with BM-purple (Roche, ref 
11442074001) at room temperature or 37ºC. Time of development was about 5 days. 
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IMMUNOFLUORESCENCE 
In paraffin sections 
Slides were incubated in xilol and solutions with decreasing concentrations of ethanol, 
washed in distilled water and PBS. Antigen retrieval was performed to break methylene 
bridges formed with fixation that cross-link proteins and mask the antigen sites. We 
used the heat-induced method with two different buffers. The most common was the 
sodium citrate but Meis antibodies worked better with Tris-EDTA buffer.  
Here are the recipes for each buffer. 
 
 
For antigen retrieval, the buffer was pre-heated in the microwave for 5 minutes. 
Samples were immersed in the buffer and heated for 20 minutes. Then, buffer with 
samples was let to temper for 20 minutes. Permeabilization was done with Triton X-
100 0.5% in PBS for 30 minutes. In the case of Cx43, Triton concentration was reduced 
to 0.25%. Peroxidase block was done, if needed, after permeabilization, using H2O2 
3% in methanol for 1 hour in darkness. To avoid unspecific binding of the antibody, 
sections were incubated with the universal TNB blocking reagent FP1012-Perkin 
Elmer, 1 hour at room temperature. Primary antibodies were incubated in the same 
TNB solution overnight at 4ºC. Secondary antibodies were incubated in PBS 1 hour at 
room temperature. Slides were always washed several times between every step with 
Citric Acid Monohydrate Sigma-33114 10mM
Distilled water 1L
Adjust pH to 6.0 with NaOH
Tween 20  0.05%
Citrate Buffer
Store at room temperature for 1 month
Trizma Base Sigma-93350 10mM
EDTA solution Sigma-E6758 1mM
Distilled water 1L
Adjust pH to 9.0
Tween 20 0.05%
Tris-EDTA Buffer
Store at room temperature for 1 month
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Tween 0.1% in PBS. Finally, slides were mounted with Dako fluorescence mounting 
medium (s3023). 
In gelatin sections 
Slides were incubated in Tween 0.1% in PBS at 37ºC for 15 minutes and washed 
several times at room temperature until gelatin was removed. Then continued with the 
steps explained before without performing antigen retrieval. 
Isolated CMs 
After fixation, PFA was carefully washed several times with PBS. Then we followed the 
same steps explained before, starting with permeabilization. For BrdU staining a step 
of DNAse digestion was needed. It was performed after permeabilization, with DNAse 
I 1:20 (Roche) for 1 hour at 37ºC. After secondary antibody, Vectashield mounting 
medium (Vector Laboratories) was added to the dishes. 
Whole mount atria from fetuses 
Atria were washed with PBS after fixation and incubated with Triton X-100 0.5% in PBS 
for 24 hours at 4ºC. Blocking reagent was incubated for 8 hours and solution with 
Wheat Germ Agglutinin (WGA-Thermo Scientific-W21404) and DAPI for three days. 
Before confocal acquisition atria were transparent with CUBIC 1 for 1 day at 4ºC 
(Susaki et al, 2015). 
Primary antibodies used: 
 
* Anti-Meis-a antibody and anti-Meis2 were generated in rabbits with a synthetic peptide corresponding 
to the conserved C-terminal domain of Meis1 and Meis2 (GMNMGMDGQWHYM) and to a Meis2-
specific N-terminal domain of Meis2 (HAPRPIPPVHHLNHGPP), respectively (Mercader, 2005). 
TARGET HOST CONCENTRATION REFERENCE
Meis a * Rabbit 1:500 Torres' Lab
Meis 2 * Rabbit 1:500 Torres' Lab
Hcn4 Mouse 1:100 Abcam ab85023
c-TnT Mouse 1:200 MS-295 Thermo Scientific
Cx43 Rabbit 1:200 Sigma C6213
CFP Goat 1:200 Acris R1091P
BrdU Mouse 1:50 Invitrogen 347580
PH3 Rabbit 1:100 Millipore 06-570
37 
 
Secondary antibodies used: 
 
HEMATOXILIN & EOSIN AND SIRIUS RED STAINING 
H&E and Sirius Red staining were performed at the CNIC Histopathology Unit. H&E 
staining was carried out using the Leica Automated Slide Stainer ST5020. For Sirius 
Red staining, the sections were brought to water and the nuclei were stained with 
Wiegerts hematoxylin. The tissue was then stained with Sirius red solution for one hour 
followed by differentiation in acetic acid and finally dehydrated and mounted in DPX.  
IMAGE ACQUISITION 
Images of the in situ hybridization were acquired with a Nikon Eclipse 90i microscope. 
H&E and SR stained sections were scanned with Hamamatsu Nanozoomer 2.0 RS 
and NDP.Scan 2.5 software. Analysis and quantifications were performed with 
NDP.Analyzer software. Immunofluorescence sections were acquired with a Zeiss 
LSM 700 confocal microscope and a Leica TCS SP8 coupled to a DMi8 inverted 
confocal microscope Navigator module equipped with white light laser. Whole-mount 
images of hearts were acquired with Nikon DXM1200F coupled to a Leica MZFLIII 
scope with a Plan Apo 1x objective. 
ECHOCARDIOGRAPHY  
In pregnant females 
In a first approach, pregnant females, with the belly shaved were anesthetized with 2% 
isoflurane in oxygen.  Abdominal surgery was then performed for uterus exposure. 
After surgery, isoflurane was adjusted to maintain a heart rate at 450±50 bpm and 
fetuses were exposed one at a time to keep them as warm as possible. An infrared 
REACTIVITY CONJUGATED CONCENTRATION REFERENCE
Rabbit A633 1:500 Life technologies A21071
Rabbit A594 1:500 Life technologies A11012
Rabbit HRP 1:500 Dako P0448
Mouse A488 1:500 Life technologies A11029
Mouse A568 1:500 Life technologies A11004
Mouse A647 1:500 Life technologies A21052
Goat Biotin 1:500 Jackson  705-065-003
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heat lamp was used for the same purpose during acquisition. Echocardiography was 
performed by an expert operator using a high-frequency ultrasound system (Vevo 
2100, Visualsonics, Canada) with a 50-MHz probe on a heating platform. 
Bidimensional (2D), M-Mode and Doppler echocardiography were used to visualize the 
hearts in long and short axis view (LAX and SAX, respectively). Left and right 
ventricular ejection fraction (EF), wall thickness and diastolic and systolic chamber 
dimensions were assessed from the M-Mode SAX view. Color flow Doppler was placed 
at the base of the left or right ventricle to visualize simultaneously the inflow and outflow 
blood pattern. Heart rate was calculated using three consecutive outflow waves. The 
position of the fetuses was recorded, so that fetal identity could be tracked for 
genotyping.  This procedure was therefore blinded to the genotype of the fetuses.  
In the second approach, pregnant females were lightly anesthetized with 0.5-2% 
isoflurane in oxygen, adjusting the isoflurane to maintain heart rate at 450±50 bpm. 
Abdominal palpation was done to identify number of fetuses and position before image 
acquisition. Transabdominal echocardiography was performed by an expert operator 
using the same ultrasound system and acquiring the same images as explain above. 
Afterwards, a small incision was done in the abdominal cavity to confirm embryo 
number and position and track fetal identity for genotyping. 
Adult mice 
Transthoracic echocardiography was performed blinded by an expert operator using a 
high-frequency ultrasound system (Vevo 2100, Visualsonics, Canada) with a 40-MHz 
linear probe on a heating platform. Mice were lightly anesthetized with 0.5-2% 
isoflurane in oxygen, adjusting the isoflurane to maintain heart rate at 450±50 bpm. A 
base-apex electrocardiogram was continuously monitored. Images were analyzed 
using Vevo 2100Workstation software. Parasternal standard, 2D and MM, long and 
short axis views at the level of the papillary muscles (LAX and SAX view, respectively) 
were acquired. 
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OPTICAL MAPPING 
The optical mapping technique provides action potential recordings at the tissue level 
with a high temporal and spatial resolution, and can be used from the subcellular level 
to the whole heart in vivo. We performed the technique in hearts from E14.5 and E16.5 
fetuses following similar protocol to previous publications by Dr. Sedmera’s group 
(Benes et al, 2014). 
Pregnant females were sacrificed by cervical dislocation and embryos were harvested 
as explained above. While hearts were dissected, embryos were placed on a petri dish 
with ice-cold Tyrode’s Buffer to prevent ischemic damage. Harvested hearts were 
placed in wells of a P12 dish on ice and incubated for 15 minutes in 500mL of cold 
Tyrode’s Buffer with 2µL of di-4-ANEPPS (Invitrogen) (dye with fluorescence voltage 
dependent) and 15µL of blebbistatin (it stops heart beat and avoids movements during 
recording) in darkness. After staining, hearts were place on a special warm dish (37ºC) 
with Tyrode’s Buffer and constant oxygen flow. Hearts were pinned and oriented for 
the desired acquisition view. Data was recorded using Ultima L high-speed camera 
and bundled software.  
 
Schematic representation of optical mapping procedure: 
 
NaCl 145mM
KCl 5.9mM
HEPES 5mM
CaCl2 1.1mM
MgCl2 1.2mM
Glucose 11mM
Adjust pH to 7.4 at 37ºC
Tyrode's Buffer
40 
 
Data analysis and maps were done with BrainVision Analysis software. AP recordings 
were processed with Medium (3x3) and High Pass (0.5) filter to reduced noise and 
derivatives were calculated. Usually, the first beat was selected for mapping and a 
spatial filter of 3x3 was applied to improve map resolution. For activation curves 
calculations, the area of each color band in each ventricle was measured and 
expressed as percentage of whole ventricular area. Limit between left and right 
ventricles was defined by hand from apex aperture to base following the septum 
shadow in bright field pictures. Heart rates were calculated from the distance between 
one AP maximum pic and the next one (data are mean of 6 beats/per heart). A-V delay 
time was determine by the time between the beginning of atrial AP and the beginning 
of ventricular AP (data are mean of 3 beats/heart). 
ADULT CARDIOMYOCYTE ISOLATION 
Adult mice were sacrificed by CO2 inhalation and the thoracic cavity was opened to 
expose the heart. Hearts were dissected and cannulated in a petri dish with Perfusion 
Buffer. The cannula was secured to the aorta with surgical thread and then placed in 
the Langendorff system (Obame et al, 2008), where Perfusion Buffer was infused for 
approximately 5 minutes until blood was removed.  
The Langendorff system enables the buffer to enter the heart through the aorta with a 
constant flux achieved by a peristaltic pump and constant temperature at 37ºC. After 
cleaning the blood, the Digestion Buffer was infused to digest the extracellular matrix 
and isolate cardiac cells. Digestion was performed for about 20 minutes. Once the 
heart was completely digested, the cannula was removed and the cardiac tissue placed 
in a petri dish for complete disaggregation with a Pasteur pipette. From this point 
onwards, steps were carried out at room temperature. Cardiac cells were filtered 
through a 100µm strain net for extracellular matrix removing and transferred to a 50mL 
Falcon tube with Stopping Buffer I. After 15 minutes of decantation, the supernatant 
was discarded and cells newly resuspended in Stopping Buffer II in a 15mL Falcon 
tube for 10 minutes. CMs are the largest cells in the adult heart, so they are the first to 
reach the bottom. Thus, short steps of decantation allow an enrichment in CMs of the 
final pool of cells. Then, cells were transferred to a new 15mL Falcon tube containing 
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T2 buffer for calcium reintroduction for 10 minutes and the step was repeated to 
incubate cells in T5 buffer. CMs were then plated on laminin-coated MatTeK glass-
bottom dishes with plating medium and incubated at 37ºC for about 2-4 hours. When 
CMs were attached to laminin, the medium was washed with PBS and 2% PFA was 
added overnight at 4ºC for fixation before immunostaining. 
 
REAGENT COMPANY CONCENTRATION
Sodium chloride Sigma - Aldrich 113mM
Potassium choride Sigma - Aldrich 4,7mM
Potassium phosphate monobasic Sigma - Aldrich 0,6mM
Sodium phosohate dibasic Sigma - Aldrich 0,6mM
Magnesium sulphate heptahydrate Sigma - Aldrich 1,2mM
Sodium bicarbonate Sigma - Aldrich 12mM
Potassium bicarbonate Sigma - Aldrich 10mM
Phenol Red Sigma - Aldrich 0,032mM
HEPES salt Sigma - Aldrich 10mM
Taurine Sigma - Aldrich 30mM
Butanodione monoxime (BDM) Sigma - Aldrich 10mM
Glucose Sigma - Aldrich 5,5mM
H2O
Perfussion buffer 1X
Liberase TM 100mg Roche Appl. Biosc 0,2mg/ml
Trypsin 2,5% Gibco 0,14mg/ml
Calcium Chloride 100mM Sigma - Aldrich 12,5µM
H2O
Perfussion buffer 1X
Fetal Bovine Serum Gibco 5%
Calcium Choride 10mM Sigma - Aldrich 12,5µM
Perfussion buffer 1X
Fetal Bovine Serum Gibco 10%
Calcium Choride 10mM Sigma - Aldrich 12,5µM
Stopping Buffer II 1X
Calcium Choride Sigma - Aldrich 100µM
Stopping Buffer II 1X
Calcium Choride Sigma - Aldrich 1mM
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PLOIDY ESTIMATION IN ISOLATED CMs 
To measure nuclear volumes and DAPI intensity in isolated CMs we acquired confocal 
z-stacks at high magnification (63X) with steps of 2µm using Zeiss LSM 700 confocal 
microscope. Image J (https://imagej.nih.gov/ij/) was used for image analysis. The first 
step was to segment the DAPI channel, for which images were filtered with Gaussian 
Blur to improve automatic recognition of nuclei. The green channel (autofluorescence) 
was used to subtract background signal in the DAPI channel and the threshold tool 
was used to create a 3D binary file. If necessary, the “fill holes” tool was applied and 
“analyzed particles” tool was used to eliminate small dots from background. The next 
step was to use 3D ROI manager to create a 3D selection around the nuclei (Ollion et 
al, 2013). Objects touching the border of the pictures were not consider for analysis. 
Finally, objects created were placed on the original DAPI channel to measure their 
volume and intensity. The same objects were used to measure BrdU intensity in the 
red channel.  
 
REAGENT COMPANY CONCENTRATION
Medium 199 Invitrogen
PEN-STREPT Lonza 100U/ml
L-Glutamine Lonza 1%
BSA Sigma-Aldrich 0,2%
NaHCO3 Sigma-Aldrich 22mM
FBS GIBCO 5%
BDM (2,3-Butanedione monoxime 10mM
Blebbistatin 25uMP
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ELECTROCARDIOGRAM 
Adult mice were lightly anesthetized with 1.5% isoflurane in oxygen and placed facing 
up on a metallic platform. Electrodes were introduced subcutaneously in each limb and 
ECG was record for about 2 minutes. 
When mice were challenged with isoproterenol, 5 minutes were recorded before 
treatment. Then, isoproterenol (3mg/kg) was injected intraperitoneal and heart beats 
were recorded for additional 20 minutes. During the last minute the isoflurane was 
turned off to observe heart conduction during the recovery phase. Experiments always 
finished before animals were completely awake, to avoid stress. Moreover, an infrared 
heat lamp was used to keep normal body temperature in mice and protective cream 
was apply in the eyes before starting the experiment. 
Analysis were performed on manually selected 40-second-fragments containing about 
300-400 beats of stable ECG. Measurements were calculated with custom MatLab 
scripts design by the group of Dr. David Filgueiras at CNIC. To detect the R-peak of 
the QRS complex we used parabolic fitting of the coiflet wavelet transformation and 
further detection of the maximum magnitude point. All R-peak detections were 
supervised to ensure accuracy of ECG segmentations. After detection of QRS 
complex, P and T waves, ECG intervals were extracted using adaptive windowing 
depending upon beat-to-beat R-R changes. Specifically: PR intervals were measured 
from the beginning or the P wave to the beginning of the R wave; QRS intervals were 
measured from the beginning of the Q wave until the lowest amplitude point of S wave; 
QT intervals were measured from the beginning of the Q wave until the point where 
the T-wave declines to 90% (T90) from the peak; QTt intervals were measured from 
the beginning of the Q wave to the point where the tangential from the beginning of T 
wave crosses the baseline. Adaptive heart-rate-corrected QT and QTt values (QTc; 
QTtc) were derived using a modification of Bazzet’s formula for murine 
electrocardiography (Mitchell et al, 1998). 
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Here is an example of how the ECG is visualized and automatically analyzed in the 
program: 
 
RNA SEQUENCING 
RNA-seq was performed in four different conditions, atria and ventricles from fetal 
hearts at E15.5 and from adult hearts to compare Meis1 and Meis2 double deletion 
(constitutive or inducible) with control littermates. In all cases, 4 replicates were used 
for each condition.  
RNA isolation 
Fetuses were harvested at E15.5 from four independent litters and a Control and a 
dKO were selected from each litter. Hearts were dissected in ice-cold sterile PBS. Atria 
and ventricles were separated and OFT removed, to be immediately frozen with liquid 
nitrogen and stored at -80ºC until all the samples were collected. Tissue lysis was 
performed with TissueLyser LT (Quiagen) and RNA isolation with RNeasy Mini Kit 
(Quiagen). 
Adult hearts from 8 male littermates were harvested two weeks after tamoxifen 
induction, as explained in previous chapters, and cannulated to clean the blood with 
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ice-cold sterile PBS. Atria and ventricles were separated and OFT removed before 
being frozen at -80ºC. Tissue lysis was done with TriReagent (Trizol; Sigma-T9424) 
using TissueLyser LT (Quiagen). Total RNA isolation was completed following RNeasy 
Midi Kit (Quiagen) protocol for RNA cleanup. 
RNA-seq library production and sequencing  
It was performed at CNIC Genomic Unit. 
20ng of total RNA were used to generate barcoded RNA-seq libraries using the 
NEBNext Ultra RNA Library preparation kit (New England Biolabs). Briefly, poly A+ 
RNA was purified using poly-T oligo-attached magnetic beads followed by 
fragmentation and then first and second cDNA strand synthesis. Next, cDNA ends 
were repaired and adenylated. The NEBNext adaptor was then ligated, followed by 
uracil excision from the adaptor and PCR amplification. Finally, the size and the 
concentration of the libraries was checked using the TapeStation 2200 DNA 1000 chip. 
Libraries were sequenced on a HiSeq2500 (Illumina) to generate 60-base single reads. 
FastQ files for each sample were obtained using bcltofastQ software 2.20. 
RNA-seq data analysis 
Read quality was assessed with FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Over-represented 
sequences were trimmed with Cutadapt 1.7.1 (Martin, 2012), which also discarded 
reads that were shorter than 30 bp. The resulting reads were mapped against the 
mouse transcriptome (GRCm38, release 91; aug2017 archive) and quantified using 
RSEM v1.2.20 (Ritchie et al., 2015). Data were then processed with a differential 
expression analysis pipeline that used Bioconductor package LIMMA (Ritchie et al., 
2015) for normalization and differential expression testing, using a paired strategy. 
Genes with at least 1 count per million in at least 4 samples were considered for 
statistical analysis. We considered as differentially expressed those genes with 
Benjamin-Hochberg adjusted p-value<0.05. Fold change and log (ratio) values were 
calculated to represent gene expression differences between conditions. 
Gene Set Enrichment Analysis was performed with genes differentially expressed 
using the Broad Institute GSEA “Molecular Signatures Database” 
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(http://software.broadinstitute.org/gsea/msigdb/index.jsp) computing overlaps with 
KEGG and Gene Ontology gene sets. 
STATISTICS  
Parametrical T student test was performed to compare two groups of data. For 
comparisons with more than two groups of data, Two-way ANOVA was used. In this 
analysis the influence of two factors, time and genotype, in the distribution of the 
sample, were studied. Chi square test was used for comparisons between observed 
and expected frequencies. Data are indicated as means ± SEM except for ECG data 
which are expressed as median ± SEM. 
All comparisons and graphs were made using Prism 7.0 statistical analysis software. 
In all cases values of P<0.05 were considered statistically significant. 
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RESULTS 
MEIS EXPRESSION PATTERN IN THE HEART 
Meis1 And Meis2 Are Expressed In Cardiac Progenitors And The Three 
Layers Of The Developing And Adult Heart: Endocardium, Myocardium 
And Epicardium. 
Determining the expression pattern of a gene is crucial to be able to understand its 
function. Thus, we performed in situ hybridization for Meis1 and Meis2 mRNAs at 
different embryonic days in the mouse heart (FIG. 9). Similar expression patterns were 
found for Meis1 and Meis2 in the developing heart. At early stages, both genes are 
expressed in second heart field progenitors, epicardium and endocardium (FIG. 9). 
However, at E14.5 we detected strong signal of Meis2 RNA in the valves while Meis1 
is almost absent in this area. 
 
Figure 9. Meis1 and Meis2 mRNA in situ hybridization. Meis1 and Meis2 mRNA 
was detected in the second heart f ield (SHF), pericardium, endocardium (Ec) and 
epicardium (Ep) in E10.5 wild type embryos. Boxed regions indicate magnifications 
shown to the right.  Panels on the right show Meis1 and Meis2 expression at E14.5. 
Magnified boxes show that expression pattern  in the atrio-ventricular valves.  Inflow 
tract (IFT), Outflow tract (OFT), Ventricle (V),  Myocardium (M), Right Atrium (RA), 
Left Atrium (LA), Left Ventricle (LV), Right Ventricle (RV).  
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Figure 10. Meis1 and Meis2 are expressed in developing cardiomyocytes.  A. 
Confocal images of embryonic ventricles at different t ime points. Immunoflu orescence 
anti-Meis-a is shown in red. B. Confocal sections of E16.5 hearts of the Meis1 -ECFP 
line combined with Meis-a immunofluorescence. Boxes indicate magnified regions 
shown below corresponding to ventricular myocardium and sub-membranous area of 
the septum. C. Immunofluorescence with anti -Meis2 ant ibody. Right panels show a high 
magnification of a ventricular myocardium region. Scale bars: 100µm in all pictures.  
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We were not able to observe a clear signal in the myocardium area with this technique 
so we tried with immunofluorescence using an antibody that recognizes Meis1 and 
Meis2 proteins. A nuclear signal for Meis was found in compact and trabecular 
myocardium throughout development (FIG. 10A).  
In order to better understand the expression dynamics of Meis in the myocardium, we 
took advantage of a Meis1-ECFP knock-in line and compared the ECFP fluorescence 
with a Meis antibody immunofluorescence at E16.5 (FIG. 10B). The ECFP signal was 
detected in myocardium of the atria and ventricles. The pattern is quite homogeneous, 
except in the septum, where a strong ECFP signal is present in the sub-membranous 
and sub-endocardial layers (FIG. 10B). The central part of the septum showed weak 
ECFP signal, while the Meis antibody stains this region. This suggests that Meis2 could 
be the prevalent factor in the central septum area as well as in the valves. Moreover, 
we confirmed these results using and antibody specific for Meis2 protein, which 
detected a nuclear signal in the valves, the septum and also the compact and 
trabecular myocardium (FIG. 10C). 
We next addressed the same question in the adult heart. We continued using the 
Meis1-ECFP tool and observed a strong signal in the sinoatrial and atrio-ventricular 
nodes and the His Bundle (FIG. 11A). The atria were also labeled, but this was not 
clear in the case of ventricular myocardium (FIG. 11A). IF for Meis and Hcn4 confirmed 
the preferential expression of these transcription factors in the CCS and in atrial and 
ventricular cardiomyocytes (FIG. 11B). To further confirm our results, we used Meis1-
CreER; R26-TdTomato as a reporter of Meis1-expressing cells upon adult tamoxifen 
administration. Hearts were harvested right after the tamoxifen induction (1mg/day for 
5 days). TdTomato reporter expression was found in the CCS, including the VCS and 
the atrial CCS with its nodes.  The strongest recombination was found in the SAN (FIG. 
11C). In addition, many CMs from the atria were labeled and several in the ventricles 
(FIG. 11C). We consider that not all CMs were labeled due to low Cre recombination 
efficiency, and the usual variability associated to the use of tamoxifen. 
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Figure 11. Meis1 and Meis2 are expressed in adult cardiomyocytes of the working 
and conducting myocardium . A. Confocal images showing expression of Meis1-ECFP 
in CCS and atrium myocardium. Sinoatrial node (SAN), Atrio -Ventricular node (AVN), 
His Bundle (HB) B. Left panels show co-immunofluorescence of Meis-a and Hcn4 in 
the SAN and AVN. Right  panels show Meis-a signal in atrial (At) and ventricular (V) 
CMs. Arrowheads in boxes point to CMs posit ive for Meis-a. Scale bar in A and B is 
100µm C. Upper panels show whole-mount R26TdTomato;Meis1-CreER hearts. Boxes 
show a magnificat ion of the SAN area. Bottom panels show thick sections of a 
R26TdTomato;Meis1-CreER heart. 
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MEIS FUNCTION IN CARDIOMYOCYTES DURING HEART 
DEVELOPMENT 
Meis1 And Meis2 Double Deletion In CMs Causes Perinatal Death 
We generated a mouse model to study the function of Meis TFs in cardiomyocytes. 
Meis1 and Meis2 were simultaneously deleted by recombination with α-MHC-Cre (FIG. 
12A).  
The recombination pattern of α-MHC-Cre is very specific for CMs (Agah et al, 1997) 
and it starts to recombine at E8.5 with some patches. We studied the recombination 
using the R26R-LacZ reporter line and observed at E10.5 the whole left ventricle is 
already recombined, while atria and right ventricle take one or two days longer for full 
recombination (FIG. 12B).  
 
Figure 12. Meis1 and Meis2 double 
deletion in developing CMs causes 
perinatal death. A. Model for 
simultaneous constitutive deletion of 
Meis1 and Meis2 in CMs. B. 
Recombination pattern of a-MHC-Cre  
in E10.5 whole-mount embryo and a 
heart section. C. Graph showing 
expected and observed frequencies of 
dKO fetuses at different embryonic 
days.  
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We analyzed the frequencies of the different genotypes at several time points. We 
noticed that at the latest stages of development, the frequency of dKO embryos was 
below the expected value (FIG. 12C). At postnatal day 1 we were not able to recover 
any dKO (FIG. 12C). These results indicate that Meis1 and Meis2 TFs are essential in 
CMs for survival at birth. 
Meis1; Meis2 dKO Hearts Present Morphological Alterations  
The next step was to analyze in detail the phenotype of dKO hearts to elucidate what 
are the alterations derived from Meis loss of function in cardiomyocytes. 
We harvested hearts at E18.5 and described external morphological alterations in the 
atria of dKOs compared to controls (FIG. 13A). The left atrium is the most affected 
presenting finger-like protrusions and a reduced size (FIG. 13B). The right atrium also 
showed finger-like structures but they were less prominent than those in the left atrium 
(FIG. 13B). The junction between right and left ventricle, at the apex, is not properly 
closed. We performed histological analysis to study internal structures and observed 
ventricular septal defects and a non-significant tendency to present thinner compact 
myocardial walls (FIG. 13C). VSD was present in 40% of the dKO fetuses at E18.5 
(FIG. 13D) and in some cases was accompanied by overriding aorta. Wall-thickness 
was measured on sections and dKO hearts showed a tendency to present thinner 
ventricular compact myocardium (FIG. 13Es). 
Harvesting hearts at earlier stages we found that dKO hearts can be clearly identified 
at E14.5 by atrial malformations, while at E12.5 only in some cases small finger-like 
protrusions can be observed in left atria (FIG. 14). Altogether, these data suggest Meis 
TFs play a role in cardiac morphogenesis.  
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In order to better understand atrial malformations we dissected atria from E18.5 hearts 
and stained them in whole mount for tissue visualization in confocal. 3D reconstruction 
highlighted the different morphology in dKO atria compared to control siblings (FIG. 
15A). Studying confocal sections in detail, we observed thinner and disorganized 
pectinate muscles in dKO when compare to control (FIG. 15B). 
 
 
 
Figure 13.  Cardiac morphological alterations produced by CM-specific Meis1 
and Meis2 deletion. A. Whole-mount E18.5 hearts from control and dKO littermates. 
Scale bar 500um. B. Left and right atrium from control and dKO hearts. Scale bar 
500um.C. H&E staining on sections from control and dKO E18.5 hearts. From left to 
right the sectioning plane progresses from dorsal to ventral. Arrow point to VSD. Scale 
bar 200um. D. Percentage of fetuses with VSD at E16.5 and E18.5. E. Graph showing 
compact myocardium thickness of control and dKO hearts at E16.5 measured in 
sections. 
.  
Figure 14.  External malformations 
in dKO hearts are visible at E14.5 .  
Whole mount images of  Control and 
dKO hearts at three different 
embryonic days. Atrial f inger-like 
protrusions are already present at 
E14.5.  
Figure 15.  Atrial malformations 
affect pectinate muscles .  A. 3D 
reconstruction of whole mount 
confocal images from Control and 
dKO atria stained with WGA at 
E18.5. B. Confocal sect ion of atria in 
panel A. Box regions indicate 
magnification shown in B’. Scale 
bar: 400µm. B’. Right atria 
magnification showing pectinate 
muscles. Scale bar: 200µm. 
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Constitutive Meis1 And Meis2 Deletion Leads To Smaller Hearts And 
Stress-induced Cardiac Rhythm Alteration. 
The morphological defects found do not necessarily explain the lethality of dKOs 
embryos at birth. Thus, we decided to explore by echocardiography the morphology 
and function of mutant fetal hearts in utero. For these experiments, pregnant females 
were anesthetized and the uterus was directly exposed for trans-uterine 
echocardiography (FIG. 16A). First, we measured the size of the interventricular 
septum and found a reduction in dKO hearts at E18.5, although it was not detected at 
earlier stages (FIG. 16B). Moreover, left and right ventricular masses were also 
reduced by the end of gestation but not before (FIG. 15B). These data, together with 
our previous result on wall thickness, determines Meis loss of function in CMs leads to 
smaller hearts. Thus, we decided to explore the possibility of defective proliferation in 
dKOs as an explanation for the smaller size. However, dKO hearts presented a non-
significant tendency to proliferate more than control hearts at E16.5 (FIG. 17). 
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Figure 16.  Echocardiography reveals smaller hearts in dKO fetuses .  A. Schematic 
representation of Echo-Doppler procedure in pregnant females. B. Graphs 
summarizing results obtain from interventricular septum (IVS) thickness, and  left and 
right ventricular masses at three different embryonic days in Control and dKO fetuses.  
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Regarding cardiac function, we were not able to detect any difference in left ventricular 
ejection fraction, at any of the developmental points analyzed (FIG. 18A). This 
observation, together with the moderate reduction in heart size suggest insufficient 
cardiac output is not the cause of lethality.  However, heart rate was found significantly 
higher in dKO embryos at the end of gestation, suggesting alterations in cardiac rhythm 
(FIG. 18B). 
Then, we decided to focus on flow pulse records through which we can detect passive 
filling of the ventricle when it is relax (E wave), the atrial contraction by the flow of blood 
coming into the ventricle (A wave) and ventricular contraction by blood flow going out 
through great vessels (Ejection wave) (FIG. 19B). Using this methodology we found 
higher frequency of arrhythmias in dKOs at different developmental stages (FIG. 19B, 
C). Looking in detail at flow pulse records from dKO fetuses, we observed changes in 
atrial contraction rhythmicity, although it is difficult to determine whether atrial 
contraction is delay or absent in some beats (FIG. 19B). These results suggest dKO 
fetuses present a tendency to tachycardia (FIG. 18B, 19B) and point to the SAN as a 
possible origin of the arrhythmia but further studies are needed. 
 
Figure 17.  Proliferation rate in the myocardium of control and mutant fetuses .  
A. Confocal section of control and dKO ventricle stained with PH3 in red and P halloidin 
in green. Arrows indicate mitotic cells. Scale bar: 25µm B. Graph showing 
quantif ication of cells PH3 + per total number of nuclei in terms of percentage. Data 
are means from 6 sections per embryo.  
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We next studied the influence of uterine exposure on the alterations in cardiac rhythm. 
For this, we implemented methodology that enabled us to record blood flows in 
embryonic hearts without surgical procedures and without losing track of fetus identity 
(FIG. 20A, B). This technique allows us to longitudinally analyze the same litter from 
E16.5 to E18.5, keeping track of individual fetuses. In this case no differences were 
found on heart rate (FIG. 20B, C), and arrhythmias did not appear in any genotype 
(FIG. 20B; 20D). These results indicate that Meis loss of function in CMs render hearts 
more sensitive to certain stress conditions associated to surgery.  We hypothesize that 
the stress of delivery and adaptation to extra-uterine life leads to cardiac rhythm 
alterations in Meis mutants that can lead to death.  
 
 
 
 
Figure 18.  dKO fetuses present normal cardiac function and higher heart rates .  
A-B. Left ventricular ejection fraction and heart rate measurements during 
Echocardiography, in Control and dKO hearts at the indicated embryonic days.  
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Figure 19.  dKO hearts manifested arrhythmias during trans-uterine echo 
acquisition.  A. Schematic representation of trans-uterine Echocardiography. B. 5 
seconds recording of blood flows in Control and dKO hearts upon uterus exposure. 
Low panels are magnification of areas in white rectangles. E -wave (E) corresponds 
to the passive fil l ing of the ventricle, A-wave (A) corresponds to the active fil l ing of 
the ventricles upon atrial contraction. Ejection (Ej) corresponds to the blood exit ing 
from the ventricles through great arteries after ventricular systole. Beats per minute 
(bpm). dKO heart show beats with no clear A wave (A?). C. Percentage of fetuses 
for each genotype that present some arrhythmic episode during Echo-Doppler 
acquisit ion after uterus exposure.  
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Figure 20.  Normal beating heart rate and cardiac rhythm in fetuses during trans-
abdominal Echocardiography.  A. Schematic representation of trans-abdominal 
Echocardiography. B. 5 Seconds blood flows of Control and dKO fetuses acquired in 
pregnant females without uterus exposure. Low panels are magnification of areas in 
white rectangles.  Pink line indicates E wave, blue, A and green, Ej.  C. Control and 
dKO hearts beating rates during Trans-abdominal Echocardiography. D. Percentage 
of normal and arrhythmic hearts found during Trans-abdominal Echocardiography.  
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Meis Deletion In CMs Leads To Slower Electrical Impulse Propagation 
Through The Ventricles 
In light of these results, we wanted to further explore cardiac conduction physiology in 
dKO hearts. Thus, we decided to characterize the electrical activity of the fetal hearts 
using the optical mapping technique (In collaboration with Dr. David Sedmera, Prague). 
Optical mapping allowed us to study the changes in voltage membrane that occur 
during the transmission of the electrical impulse through the heart. 
We first started with E14.5 hearts when technically optical mapping is more likely to 
succeed and Meis should already be completely deleted but no overt morphological 
alterations are found in ventricles. We recorded approximately 16 seconds per heart 
and measured different parameters. Heart rates were similar between controls and 
mutants (FIG. 21A, B). We observed a non-significant tendency to a shorter delay 
between atrial and ventricular depolarization in mutants (FIG. 21C, D). 
Analysis of voltage maps revealed a slower activation curve in the left and right 
ventricle of hearts lacking Meis compared to controls, mostly due to a delay during the 
first two milliseconds of ventricular depolarization (FIG. 22A,B). This parameter reflects 
the conduction velocity and therefore suggests an impairment of electrical propagation 
in mutants. We studied the atrial activation curve but we did not detect significant 
differences in this case (FIG. 22C). However, we cannot discard conduction anomalies 
in atria because of a very high variability among maps of the same experimental group 
due to the irregular atrial surface. 
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Moreover, we calculated total area of ventricles and atria to assure the changes in 
activation curve are reflecting changes in depolarization velocity and not in heart size 
(FIG. 22D). These results suggest that constitutive double deletion of Meis1 and Meis2 
in cardiomyocytes impairs electrical impulse transmission through the ventricles. 
Figure 21.  Heart beat rate and Atrio-Ventricular delay measured by Optical 
Mapping.  A. Bright f ield image of Control and dKO hearts (dorsal view) during optical 
mapping. Peaks on the right show action potentials of a particular dot in the ventricles 
(*) along 400 ms. B. Quantif ication of heart beat rate (HR) in Controls and dKOs during 
optical mapping at E14.5. Data are means of 5 consecutive beats per heart. C.  Bright 
f ield image of Control and dKO hearts (dorsal view angled to visualize the atria) during 
optical mapping. Peaks on the right show one action potential from atrium (white *) 
and ventricle (red *) of a selected dot along 40 ms. D. Quantif icat ion of t ime between 
atrial and ventricular activation in Control and dKO hearts during optical mapping. 
Data are means of 3 consecutive beats per heart.  
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We next studied the same parameters two days later in development, at E16.5. We 
noticed dKO hearts were frequently not beating by the time of recording (FIG. 23A), 
suggesting dKO hearts were extremely sensitive to the technique. Measurements of 
heart rate and A-V delay were similar in both groups (FIG. 23B, C) and activation 
curves too (FIG. 23D, E). We speculate that we were not able to find significant 
differences because, likely, the non-beating hearts were the ones presenting a more 
severe phenotype. It is important to mention that, even though the time of recording 
was very short, we detected three dKO hearts that were temporally arrhythmic, two at 
Figure 22.  dKO hearts present slower ventricular activation curves .  A. 
Representat ive Control and dKO optical maps of ventricular depolarization. * indicates 
the area where the first AP appears. White line shows ma nual division of left and right 
ventricle for analysis. Color bar shows temporal scale in the maps (1 color= 1ms). B. 
Left and right ventricular activat ion curves showing depolarized area (%) per 
mill isecond obtain from optical mapping data (n=8/group). C.  Atrial activation curve 
from atria (n=8/group). D. Total area of left and right ventricles and atria in Control 
and dKO groups. All data are from more than three independent l it ters.  
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E14.5 and one at E16.5 (FIG. 24). None of the control hearts showed changes in 
rhythm.  
 
 
 
Figure 23.  Optical mapping at E16.5 did not show any significant diffe rence 
between Control and dKO hearts .  A. Beating proportion of hearts at E16.5 by the time 
of optical mapping recording. B-C. Heart rates and A-V delay times of Control (n=11) 
and dKO (n=5) beat ing hearts. D. Maps and curves of left and right ventricular 
activation times in Control and dKO at E16.5. * indicates the area where the firs AP 
appears. Color bar shows temporal scale from 0 to 16ms. E. Atrial activation curve. F. 
Total area measured in each heart from every region analyzed.  
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MOLECULAR MECHANISMS GOVERNING MEIS1 AND MEIS2 DKO 
PHENOTYPE. 
Meis Deletion In CMs Alters The Expression Of Genes Related To Cardiac 
Conduction 
Our last objective was to unravel the molecular mechanisms responsible for the mutant 
phenotype. We performed RNA-seq analysis in atria and ventricles separately, at 
E15.5. We found more differentially expressed genes (DEGs) in atria (1281) than in 
ventricles (268) (Supp. table 2, 3), which might explain the morphological alterations 
affecting atria. GSEA analysis of DEGs in the KEGG database showed downregulation 
of important genes for calcium signaling (RyR3, Cacna1h, Cacna1c) and cardiac 
muscle contraction (Myl2, Myh7) in the ventricles (FIG. 25A). The changes detected in 
the atria were more pronounced, including not only calcium and contraction alterations 
but also genes involved in focal adhesion, Wnt signaling and genes associated with 
various cardiac pathologies (FIG. 25B). 
Figure 24.  Arrhythmic dKO hearts detected by optical mapping .  A. Bright f ield 
pictures and signals recorded by optical mapping in two E14.5 (10x) and E16.5 (4x) 
dKO hearts. B. Percentage of arrhythmic dKO hearts found at each time point.  
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Figure 25.  RNA-seq analysis of E15.5 Control vs dKO atria and ventricles .  A-B. GO 
plots showing DEGs in dKO ventricle (A) and atria (B) that belong to signif icantly enriched 
KEGG database categories, as indicated.  
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In addition, we found that Gja1, the gene encoding Cx43, was significantly 
downregulated in atria and ventricles of dKO hearts at E15.5. Immunofluorescence of 
Cx43 supported the RNA-seq finding (FIG. 26A, B) and is consistent with the slower 
ventricular depolarization observed by optical mapping. 
 
There are different studies relating downregulation of Cx43 with the appearance of 
arrhythmias. Thus, we hypothesize that downregulation of Meis1 and Meis2 in 
developing cardiomyocytes leads to misregulation of calcium signaling and 
downregulation of Cx43, which contributes to the development of lethal cardiac 
arrhythmias by the end of gestation. 
 
 
 
Figure 26.  dKO hearts present reduced Cx43 expression .  A. Confocal images of 
ventricular myocardium stained for Cx43 in red and phalloidin in green. Scale bar: 
100µm B. Graph showing the quantif ication of Cx43 expression/myocardium area 
(pixel2).  
 
68 
 
MEIS FUNCTION IN CARDIOMYOCYTES DURING ADULTHOOD 
To further explore the function of Meis in cardiomyocytes we developed an inducible 
mouse model that allowed us to study Meis role in adult CMs. We used the driver α-
MHC-MerCreMertg/wt. This Cre driver is also specific for CMs but recombination will 
only be induced in the presence of tamoxifen (Tx) (FIG. 27A). We used mice around 
10 weeks of age and oral-gavage tamoxifen was administered at 1mg/day for five 
consecutive days (FIG. 27B). 
Meis1 And Meis2 Double Deletion In Adult CMs Causes Cardiac 
Hypertrophy And Interstitial Fibrosis 
Echocardiography analysis showed increased left ventricular mass and left ventricular 
posterior wall thickness in Meis1flox/flox;Meis2flox/flox;α-MHC-MerCreMertg/wt (idKO) 
hearts compared to Meis1flox/flox;Meis2flox/flox;α-MHC-MerCreMerwt/wt (Control) (FIG. 
27C, D). The change was evident two weeks after tamoxifen induction and was 
maintained along the time-course of the experiment (FIG. 27D). Nonetheless, left 
ventricular ejection fraction was conserved between groups, indicating normal systolic 
function (FIG. 27D). The E/A ratio was preserved, also indicating absence of diastolic 
dysfunction (FIG. 27D). 12 weeks after tamoxifen induction, heart weight to tibia length 
ratio showed a non-significant tendency of idKO hearts to present larger size compared 
to controls (FIG. 27E, F). 
Histological analysis revealed that Meis deletion in adult CMs induced interstitial 
fibrosis (FIG. 28A). Fibrosis was present at 4w after tamoxifen induction and 
maintained without further increase during 12 weeks of follow-up. Since it was 
described that α-MHC-MerCreMer may produce cardiac toxicity in the presence of 
tamoxifen (Koitabashi et al, 2009; Bersell et al, 2013), we decided to characterize a 
model of Tx administration to MerCreMer carriers of this allele in the absence of Meis 
floxed alleles. Sirius red staining at 4 weeks upon tamoxifen administration revealed 
slightly more interstitial collagen deposition in α-MHC-MerCreMertg/wt mice (CRE) than 
in their wild type siblings (WT) (FIG. 29A, B).   
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Figure 27. Meis1 and Meis2 inducible deletion in adult hearts leads to mild-
hypertrophy. A. Mouse model for the simultaneous deletion of Meis1 and Meis2 in 
adult CMs. B. Schematic representation of analysis t iming and tamoxifen treatment 
during the experiment. C. Echocardiography images of ventricular walls in short axis 
and mono-dimensional mode 12 weeks after tamoxifen treatment in Control and idKO. 
Green line shows ECG of the mouse during the study. D. Graphs summarizing the 
results obtained after Echo analysis regarding left ventricular posterior wall thickness 
(LVPW), left ventricu lar mass (LV mass), Left ventricular ejection fraction (LV EF) and 
ratio E/A. P values represent Two-way ANOVA results for genotype factor. E. Whole -
mount images of hearts harvested 12 weeks after Tx administration. F. Graph showing 
ratio between heart weight and tibia length of Control and idKO hearts harvested 12 
weeks after Tx. 
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The amount of collagen deposition was, however, much below that observed in idKO 
hearts and similar to mice used as Control, so we considered unlikely that the toxicity 
of the MerCreMer significantly influences the histological characterization of idKO 
hearts. Collagen deposition alone could explain the mild hypertrophy developed in 
idKOs, however it is also possible that cardiomyocyte hypertrophy or proliferation 
contribute to the phenotype. 
 
Figure 28 Meis1 and Meis2 loss of function in adult CMs induces interstitial 
fibrosis.  A. Adult heart sections stained with Sir ius Red to study collagen deposition.  
Scale bar: 500 µm. Black boxes show magnification of ventricular myocardium. Scale 
bar: 100µm. B. Graph indicat ing the area percentage posit ive for Sir ius Red, 4 and 12 
weeks after Tx. Data obtained as mean of posit ive area in ventricles from 3 sections 
per heart.  
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Loss Of Function Of Meis1 And Meis2 In Adult CMs Leads To 
Polyploidization Of Mononucleated CMs 
Trying to sort out the origin of mild-hypertrophy in idKO mice, we administered BrdU in 
the drinking water for three weeks (starting 1 week after tamoxifen induction ceased) 
and isolated CMs by Langendorff perfusion, immediately after BrdU administration 
ended (FIG. 30A). After they adhere to the culture dish, areas occupied by single 
cardiomyocytes were measured on CMs populations classified by their nucleation 
(mononucleated, binucleated and polynucleated). No significant size differences were 
found between control and idKO cardiomyocytes (FIG. 30B, C). 
Then, we evaluated the proliferation status of CMs in both groups. Quantification of 
BrdU positive CMs revealed a significant increase of BrdU-positive CMs in idKO hearts 
that was preferential for the mononucleated population (FIG. 30D, E). The percentage 
of bi and polynucleated CMs that incorporated BrdU in the nuclei were also elevated 
in idKO hearts, although not significantly (FIG. 30E). 
Figure 29. α-MHC-MerCreMer carrier mice develop mild interstitial fibrosis .  A. 
Adult heart sections stained with Sir ius Red (SR) to study collagen deposition  in α-
MHC-MerCreMer t g /w t and their wild type siblings. Black boxes show magnification of 
ventricular myocardium. B. Graph indicating area percentage posit ive for Sir ius Red.  
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In order to determine whether this DNA synthesis was linked to proliferation or to 
endoreplication, we estimated the ploidy of mononucleated CMs by DAPI intensity, 
nuclear volume and cell size. We found that the nuclei that had incorporated BrdU 
exhibited approximately double DAPI intensity and double cell size compared to BrdU-
negative cardiomyocytes (FIG. 31A, B, C). However, we were not able to detect 
differences due to genotype in this parameters. Classification of mononucleated CMs 
according to their nuclear volume showed roughly two cell populations –likely 2n and 
4n– with similar distributions in control and idKO hearts (FIG. 31D, E). These results 
suggest that the majority of spontaneous BrdU incorporation by mononucleated adult 
cardiomyocytes is related to polyploidization and not proliferation. 
Figure 30. idKOs show normal CM size and increased BrdU incorporation in 
mononucleated CMs .  A. Schematic summary of the experimental design. B. Confocal 
images of isolated CMs from Control and idKO hearts. Scale bar 50µm. C. 
Quantif ication of single CM areas, classif ied by number of nuclei per cell. D. Confocal 
images of isolated CMs from Control and idKO hearts showing BrdU incorporat ion. 
Scale bar 50µm. E. Quantif ication of BrdU+ CMs classif ied by number of nuclei per 
cell. MONO, n≈250 cells; BI, n≈3000 cells; POLI, n≈150 cells.  
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Double Inducible Deletion Of Meis1 And Meis2 In Adult CMs Causes 
Slower Ventricular Conduction 
Taking into account that we found that Meis TFs are preferentially expressed in adult 
CMs of the conduction system and that are necessary for the establishment of 
ventricular conduction during development, we decided to perform electrocardiograms 
of the inducible deletion adult model.  
We followed the same experimental timing as before (FIG. 32A), performing ECG at 
different time points after Tx induction. We found progressive elongation of the QRS 
complex in the idKO mice (FIG. 32B, C). P, PR and QTc showed no significant 
differences between genotypes (FIG. 32C). However, QTtc which is a more robust 
measurement for QT interval, showed and increased in idKO at 2 weeks, that seems 
Figure 31. The majority of BrdU+ mononucleated CMs undergo DNA endoreplication 
and not proliferation.  A. Confocal image of isolated CMs from idKO adult hearts showing 
differences in mononucleated CM size. Arrowheads point to mononucleated CMs, in pink 
for BrdU+ CMs and in white for BrdU- CMs. B. Quantif ication of the DAPI intensity of 
mononucleated CM nuclei from Control and idKO hearts. C. Graph showing 
mononucleated CM size depending on BrdU incorporation and genotype. D -E Histogram 
of nuclear volume of BrdU+ and BrdU- mononucleated CMs from Control and idKO mice.  
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to be ameliorated along time (FIG. 32C). Moreover, QRS amplitude significantly 
dropped in mutant mice at the first point analyzed and the decreased is maintained 
during the experiment (FIG. 32B, C). This result suggest that atrial and atrio-ventricular 
conduction are normal while ventricular conduction is impaired in idKOs mice. 
We also checked whether QRS and QTtc intervals were normal in MerCreMer carrier 
animals. Comparing CRE and WT animals we did not detect any significant QRS and 
QTtc elongation (FIG. 33A, B), supporting the idea that slower ventricular conduction 
is a consequence of Meis1 and Meis2 double inducible deletion in the adult heart. In 
addition, we measured QRS amplitude, which appeared significantly decreased in 
MerCreMer carriers after Tx treatment. This indicates that Meis loss of function may 
not be responsible for QRS amplitude drop. 
Altogether, these data demonstrate Meis TFs are necessary for normal adult heart 
homeostasis and electrical conduction. Moreover, it suggests that Meis could be 
controlling similar processes in development and adulthood, related to normal 
ventricular impulse propagation. 
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Figure 32. QRS complex is elongated upon Meis1 and Meis2 double deletion in 
adult CMs.  A. Representation of experimental design. B. Control and idKO ECGs from 
anesthetized adult mice at basal and 4w experimental points. C. Graphs indicating 
measurements of the duration of the different ECG intervals (P, PR, QRS, QT and 
QTt) and QRS amplitude (mV) in controls and idKOs at the indicated experimental 
t ime points. 
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MOLECULAR MECHANISMS UNDER THE CONTROL OF MEIS1 AND 
MEIS2 IN ADULT CARDIOMYOCYTES. 
Meis1 And Meis2 Regulate Calcium Signaling And Conduction System 
Markers 
To further explore the function of Meis TFs in adult CMs we aimed to understand what 
molecular changes take place upon inducible deletion of Meis1 and Meis2. We 
performed RNA-seq analysis 2 weeks after Tx administration separately from adult 
atria and ventricles. 263 DEGs were found in the ventricles, while only two changed in 
atria (FIG. 34A) (Supp. Table 4, 5). Therefore, we studied the possibility of low 
efficiency Cre recombination in the atria. Specific quantification of Meis1 exon 8 and 
Meis2 exon 3 in the RNAseq showed efficient deletion of both exons in ventricles, but 
almost no reduction in atria (FIG. 34B). These findings suggest low efficiency of 
MerCreMer in atria and could explain the absence of changes in that region.  
We performed gene set enrichment analysis in the KEGG database and found that 
DEGs are mainly related to cardiomyopathies and calcium signaling pathway (FIG. 
35A). Genes regulating sodium currents in CMs, Scn5a and Scn10a, are significantly 
downregulated, suggesting sodium current might be also deficient in idKO mice (Supp. 
Table 5).  
 
Figure 33. Measurement of ECG intervals in MerCreMer carriers .  Graphs showing 
comparisons between CRE mice and their WT siblings before and after Tx treatment 
for QRS (A) and QTc times (B) and QRS amplitude (C).  
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Moreover, genes related to Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) 
appeared as the most related gene set. We decided to compare our RNA-seq data 
with a published RNA-seq from an ARVC mouse model in which Pkp2 has been 
conditionally deleted in cardiomyocytes (Cerrone et al, 2012b). Pkp2 is a desmosomal 
protein important for the assembly of CMs. In this model, Meis1 and Meis2 appeared 
significantly downregulated (FIG. 35B green color). Moreover, when we compared the 
differentially expressed genes in both models we found a correlation between the 
genes that were changing, especially when focused on the most significantly 
downregulated ones, such as Cacna1c or RyR2, essential for calcium signaling (FIG. 
35B). Gja1, appeared downregulated in both models too. Furthermore, Hcn4 and 
Cntn2, which are CCS markers, were reduced in idKO ventricles, suggesting a possible 
affection of the VCS. 
Altogether, it is possible that, alterations both in working and conducting myocardium 
are contributing to QRS elongation in idKO adult hearts. 
Figure 34. The -MHC-MerCreMer allele does not recombine efficiently in the atria 
of adults.  A. Number of DEGs found in atria and ventricles by RNA-seq analysis of 
Control vs idKO hearts. B. Quantif ication of Meis1 exon8 and Meis2 exon 3 in RNA-
seq from atria and ventricles. C. Number of statically signif icant upregulated and 
downregulated genes in idKO ventricles.  
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Figure 35. ARVC and calcium 
signaling related genes appeared 
differentially expressed in idKO 
ventricles.  A. GOplot summarizing 
results from GSEA analysis. Genes 
and fold changes are represented on 
the left, and on the right, the 
associated categories to each gene. 
B. Volcano plot representing genes 
expressed in PKP2 cKO model (grey 
dots) and DEGs in idKO ventricles 
(blue dots are downregulated genes 
and red upregulated). We only 
considered for this analysis 
expression changes with adj. p-value 
<0.05 (black line). Number in the 
right are the overlapping genes 
regarding signif icance and fold 
change direction.  
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Cx43 Is Reduced And Mislocalized In idKO Ventricular Myocardium 
We decided to study Cx43 expression because it was reduced in developing CMs 
when Meis1 and Meis2  were absent, and appeared downregulated in RNA-seq data 
from adult idKO. Immunofluorescence of Cx43 revealed a significant reduction of the 
protein in idKO ventricles (FIG. 36A, B). The reduction was already evident 4 weeks 
after tamoxifen administration. On the contrary, analyzing the atria, the same levels of 
expression were found between controls and idKO (FIG. 36C, D). These results are 
consistent with RNA-seq data, since DEGs genes where mainly found in the idKO 
ventricles.  
 
 
 
 
Figure 36. Cx43 expression is reduced in idKO ventricular myocardium .  A. 
Confocal images of Control and idKO ventricular myocardium 4 weeks after Tx, 
stained for Cx43 (red) and Phalloidin (green). B. Quantif ication of Cx43 signal per 
myocardial area (pixel2) in ventric les. C. Confocal images showing atria sections 
with the same staining as in A. Scale bars in A and B are 50µm. D. Quantif ication 
of Cx43 signal per myocardial area (pixel2) in Atria.  
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Acute Isoproterenol Treatment Does Not Preferentially Induce 
Arrhythmias in Meis1 and Meis2 idKO. 
In the light of these results, we wondered whether idKOs could be more prone to the 
development of arrhythmias under certain conditions. The mouse model for ARVC 
mentioned above, developed arrhythmias after being challenged with the beta 
adrenergic receptor, isoproterenol. Thus, we decided to reproduce the same challenge 
in idKOs (FIG. 37A). To corroborate that the treatment was affecting the hearts we 
measured the RR segment and found a reduction in length without differences between 
mutant and control mice. Since isoproterenol increases heart rate, the reduction in RR 
time corroborated the treatment was effective. (FIG. 37B, C). No significant differences 
between control and idKO hearts were found either in QRS elongation or any other 
ECG segments, although idKOs showed normalized QRS length by T2 (FIG. 37D). 
Sporadic arrhythmias were observed in some mice but were not related to the 
genotype (Table 1).  
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Figure 37. idKO mice respond similar to Controls after acute isoproterenol 
treatment.  A. Schematic representat ion of ECG recording timing in anesthetized 
mice with isoproterenol induction. T0-T3 represent fragments selected for analysis. 
B. Representat ive ECG fragments of Control and idKO mice before and after 
isoproterenol injection.  Boxes represent magnifications of a representative cardiac 
cycle. C-D. Graphs representing RR and QRS duration in Control and idKOs at the 
different t ime points analyzed.  
 
Table 1. Arrhythmic episodes after 
isoproterenol injection where not 
related to genotype .  Table shows the 
number of mice with sporadic 
arrhythmic events during ECG 
recording after acute isoproterenol 
treatment. 
Mice with 
arrhythmic episodes
Total 
mice nº
CONTROL 3 5
idKO 2 5
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POSSIBLE DIRECT TARGETS OF MEIS TFS IN CARDIOMYOCYTES 
Taking advantage of all the RNA-seq data collected in this thesis we looked at genes 
differentially expressed in all the tissues and conditions studied. We found 28 genes 
that changed expression in developing atria and in both developing and adult ventricles 
(FIG. 38A). The fact that these genes change expression in different contexts suggests 
they could represent direct targets of Meis TFs in CMs. Gene ontology analysis for 
biological processes related 16 of those genes with regulation of transport, secretion, 
heart development and contraction (FIG. 38B). Gja1, Nppa, Wnk1, Corin and Cacna1c 
were implicated in the majority of the processes altered, suggesting they could play a 
central role in the phenotype (FIG. 38B). On the other hand, Fhl2, Lrrc10 and Efnb3 
appeared as the most downregulated genes (FIG. 38B). Thus, we decided to look at 
previous Meis ChIP-seq data from the lab (Longobardi et al, 2014; Delgado I et al. 
unpublished) to elucidate whether Meis TFs could bind directly to some of those genes 
or their previously described regulatory regions (Shen et al, 2012). ChIP-seq data from 
E10.5 embryos and E11.5 embryo trunks, including the heart, revealed putative binding 
sites of Meis in 5 of the 28 genes and regulatory regions studied: Cacna1c, Clic4 
(Chloride intracellular channel), Gpc1 (Glypican 1), Pam (Peptidylglycine-alpha-
amidating-monooxygenase) and Prps2 (Phosphoribosyl pyrophosphate synthetase 2) 
(FIG. 39). In addition, we detected putative Meis binding sites in Scn5a and Wnt11 
genes, which although not included in the 28 genes commonly changed in all 
conditions, might also have an important relation with the phenotype describe. 
These results suggest that these identified genes could be directly regulated by Meis 
transcription factors, thereby playing a central role in the development of the 
phenotypes describe in this project.  
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Figure 38. Analysis of coincident DEGs in the 3 RNA-seq experiments performed 
reveals putative direct targets of Meis TFs.  A. Comparison of DEGs found in all RNA-
seq studies performed in this project (atria and ventricles from adult and embryonic 
hearts). B. GO biological processes enrichment analysis performed with the 28 common 
DEGs found between adult ventricles and developing atria and ventricles. Fold changes 
rectangles, from outer to inner, correspond to: Adult ventricle, embryonic ventricle and 
embryonic atria, respectively.  
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Figure 39. Putative binding sites of Meis found by ChIP-seq analysis.  Representation 
of the genes with statically signif icant peaks in Meis -a ChIP analysis from E10.5 embryos 
and E11.5 trunks. Blue triangles represent the peaks and salmon line the regulatory 
regions described in Shen et al., 2012, for each gene.  
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DISCUSSION 
In this thesis project we have investigated the role of Meis1 and Meis2 transcription 
factors in the developing and adult cardiomyocytes. We have found Meis1 and Meis2 
co-expression in developing CM is essential for perinatal survival and in adult CMs to 
maintain a normal tissue homeostasis. Nonetheless, discussion is needed to put in 
context the value of these results, elucidate possible controversial results and propose 
future directions suggested by this research. 
MEIS EXPRESSION PATTERN IN THE HEART  
Using mRNA in situ hybridization in wild type mouse embryos, we have described for 
the first time that Meis1 and Meis2 are expressed in SHF progenitors, epicardium and 
endocardium. Moreover, combining two different approaches, immunofluorescence 
and a Meis1-CFP reporter line, we have been able to describe in detail the expression 
pattern of Meis1 and Meis2 in the developing myocardium. Previous studies relating 
Meis1 function with heart development did not analyze protein expression in this organ 
(Stankunas et al, 2008; González-Lázaro et al, 2014). In addition, we have identified 
that Meis2 is expressed in cardiac valves while Meis1 is not. These results are in 
accordance with previous data published by the group of Dr. Kozmik in 2015, where 
the Meis2 expression pattern was analyzed in embryos at E13.5 and showed 
expression in the valves and surrounding cardiomyocytes (Machon et al, 2015) .  
Regarding Meis1 and Meis2 expression in the adult heart, nothing was previously 
reported. The work of Dr. Sadek, in 2013, studied the expression of Meis1 in the 
neonatal heart. They proposed that Meis1 is expressed after birth in CMs, but located 
in the cytoplasm around the nuclei and at P7 Meis1 is translocated to the nucleus 
(Mahmoud et al, 2013). However, in our experiments we always detect Meis signal in 
the nucleus, both in E18.5 fetuses and adult hearts.  
Our expression studies show a previously undescribed preferential expression of Meis 
TFs in the adult CCS. Meis IF and lineage tracing of Meis-expressing cells in adult 
hearts, showed that the expression of Meis TFs is stronger in CCS CMs than in the 
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working myocardium. This indicates that Meis could play an important role in CCS 
function or homeostasis, which is in accordance with GWAS studies in different human 
cohorts that have associated intronic Meis1 SNPs with PR interval elongation (Pfeufer 
et al, 2010; Smith et al, 2011a; Butler et al, 2012b). 
MEIS IN DEVELOPING CARDIOMYOCYTES 
In this study, we have determined that double Meis1 and Meis2 deletion in developing 
CMs leads to perinatal death, probably due to ventricular cardiac arrhythmias. We 
described morphological alterations in dKO hearts that are not sufficient to explain the 
lethality of the fetuses, provided the EF is preserved. However, these results also 
pointed out to a role of Meis TFs in cardiac morphogenesis and in particular, in atrial 
and interventricular septum formation. Previous studies on Meis1, already described 
IVS defects upon Meis1 complete deletion (Stankunas et al, 2008; González-Lázaro 
et al, 2014). Nevertheless, in the first study cardiac defects were though to derive from 
a possible role of Meis1 as a partner of Pbx in CNC progenitors, but in our model Meis1 
is deleted specifically in CMs and this is sufficient to reproduce the IVS defects.  
The atrial finger-like protrusions described in Meis1 and Meis2 dKO hearts have never 
been reported before, suggesting that Meis1 or Meis2 loss of function, independently, 
are not enough to produce this phenotype. We do not know the exact mechanisms 
underlying this malformation. RNA-seq data allowed us to speculate that extracellular 
matrix, CM coupling and focal adhesion, might be involved. Plakophilin 2 (PKP2) and 
Desmocollin 2 (Dsc2) are important proteins for desmosome formation and both are 
downregulated specifically in the developing atria. In addition, Wnt5a and Wnt11, 
regulators of planal cell polarity, are significantly downregulated. Thus, we hypothesize 
that defects in non-canonical Wnt signaling directly regulated by Meis could lead to CM 
misalignment and failure to form proper intercalated discs, which might contribute to 
disorganized tissue growth. We plan to study more in detail the atria, regarding relative 
pectinate muscles volume-to-lumen proportions, orientation of division planes and CM 
ultrastructure by electron microscopy, in order to unravel the mechanisms of the atrial 
malformation in Meis1; Meis2 dKOs.  
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RNA-seq data also revealed alterations of Gja1 (coding for Cx43 gap junction) in 
embryonic atria and ventricles. In addition, important genes for calcium signaling such 
us Cacna1c (coding for Carv1.2), RyR2 (coding for Ryanodine Receptor 2) and Atp2a2 
(coding for SERCA2), where downregulated upon Meis1 and Meis2 double deletion in 
CMs. A mouse model with a Cacna1c mutation leads to lethal arrhythmias at birth 
(Domes et al, 2011) and different studies in mouse models reported that more than 
50% reduction in Gja1 expression can lead to ventricular arrhythmias and sudden 
death around P21 (Gutstein et al, 2001).  
All these data, together with the fact that we did not detect an impairment in cardiac 
function, support our hypothesis on postnatal lethal cardiac arrhythmias occurring in 
dKO embryos. Moreover, the reduction in Cx43 expression and the slower 
depolarization rates observed by optical mapping strongly support this view. 
Nevertheless, we have not been able to detect cardiac rhythm alterations by non-
invasive echocardiography on pregnant females. It was only after surgically exposing 
the uterus when the alterations appeared. One possibility is that dKO embryos might 
be more sensitive to temperature changes, so when the temperature drops, the heart 
rate is slower and cardiac arrhythmias manifest. This might also be the explanation for 
the low proportion of mutants that show beating after cesarean dissection of fetuses at 
E16.5 during optical mapping.  
An interesting future experiment, would be harvesting fetuses at E18.5 and reanimate 
them to perform ECG and record the possible arrhythmic events before death. We also 
plan to better investigate blood flows recorded in embryonic hearts by 
echocardiography, where we can visualize atrioventricular blocks, changes in SAN 
rhythm and heart rate variability. Thus, we will have more information about the 
possible origin of the arrhythmia. 
MEIS IN ADULT CMs 
We showed that Meis1 and Meis2 double inducible deletion in adult CMs leads to an 
increase in ventricular mass and wall thickness with preserved ejection fraction. The 
mild hypertrophy observed might not be a primary effect of Meis loss of function and it 
does not progress to heart failure in the temporal window explored in this work. A 
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possible explanation for the preserved cardiac function is that the increase in cardiac 
size is not as severe as in other models of hypertrophic cardiomyopathy (Nakamura & 
Sadoshima, 2018; You et al, 2017). Moreover, we were not able to detect significant 
differences in the size of CMs of idKO hearts. One possibility is that the mild increase 
in heart size might be mainly due to the interstitial fibrosis observed with preserved 
number of CMs and contractile function.  Nonetheless, it is important to mention that 
histological images with SR staining in control and idKO (FIG. 27A) suggested that a 
local CM hypertrophy, not detected in the global quantifications, could be happening 
close to the regions with higher increase in collagen deposition. This opens the 
possibility that there is local CM death leading to fibrosis and hypertrophy of the 
surrounding CMs for function compensation. If this was the case, the percentage of 
hypertrophic CMs would be small and upon Langendorff isolation, they would dilute 
out in the sample so that the differences may not be detectable. We are currently 
measuring CMs area in sections to address this possibility. 
An alternative to this idea would be that mild CM hyperplasia might underlie the 
increase in cardiac mass.  This would be functionally compensatory and fit with the 
previous reports that link Meis activity and CM exit of the cell cycle (Mahmoud et al, 
2013, 2014). Therefore, we also explored CM proliferation as another possible factor 
contributing to the increase of ventricular mass in idKOs. We described here a 
significant augment of BrdU incorporation in mononucleated CMs of idKOs hearts, 
however this did not result in actual CM proliferation. Instead, mononucleated CMs 
became polyploid and increased size. This increase in size of the BrdU+ 
mononucleated CMs in idKOs likely has a very small contribution to the hypertrophic 
phenotype, since it represents a very small percentage of the total CM population. 
These results are apparently contradictory with those reported by the Sadek lab, where 
Meis1 is proposed as a negative regulator of postnatal CMs proliferation. In fact, after 
Meis1 deletion in neonatal CMs, Mahmoud et al., found increased CM proliferation and 
a higher number of mononucleated CMs by P7. In addition to characterizing 
proliferation, we have specifically looked for the expression of genes related to cell 
cycle that were described in the perinatal deletion of Meis1 by Mahmoud et al., but we 
did not detect changes in these factors in the Meis1 and Meis2 adult mutants. We think 
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there are two possible explanations for this, either the function of Meis1 in adult CMs 
is different to that in perinatal stages, which has not been explored here, or in adult 
CMs the absence of Meis function is not enough to induce the complete cell division 
process, so it only increases DNA synthesis.  
ECG analysis in control and idKOs pointed out possible alterations in conduction 
velocity upon Meis1 and Meis2 deletion in adult CMs. We detected that idKOs have a 
prolonged QRS complex, which correlates to what we found in dKO fetuses by optical 
mapping. QRS elongation in humans is a risk factor for ventricular fibrillation (Elhendy 
et al, 2005; Desai et al, 2006) but it does not always correspond with a slower 
ventricular conduction velocity. It has been reported that increased cardiac mass 
together with normal conduction velocity can also lead to longer QRS complexes 
(Wiegerinck et al, 2006). The most important determinant of ventricular conduction 
velocity is the sodium current mainly generated by channels encoded by Scn5a. RNA-
seq data from adult ventricles showed Scn5a expression is significantly reduced in 
idKOs, suggesting that a defective sodium current might underlie the slower ventricular 
conduction and QRS elongation in our model. It would be very interesting to measure 
this current by patch-clump in both CCs and working-myocardium CMs to corroborate 
these results at the single-cell level.  
The reduced Cx43 expression and the interstitial fibrosis might also contribute to QRS 
elongation. Several mouse models have shown that reduction in Cx43 expression is 
associated with slower ventricular conduction velocity accompanied by increased 
incidence of arrhythmias and sudden cardiac death (Gutstein et al, 2001; Danik et al, 
2004; van Rijen et al, 2004; Lerner et al, 2000). Moreover, rapid Cx43 remodeling or 
redistribution to the lateral membrane has been found in patients with various cardiac 
diseases, such as cardiac hypertrophy or dilated cardiomyopathy (Lambiase & Tinker, 
2015; Severs et al, 2004). Several genes related to these diseases appear altered in 
idKOs hearts, as the gene set enrichment analysis pointed out, however we did not 
observed dilation in mutant hearts. 
Furthermore, it has been proposed that reduced adhesion between cardiomyocytes 
might lead to mechanical stress and induce cell death (Moncayo-Arlandi & Brugada, 
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2017; Basso et al, 2009). According to this idea, interstitial fibrosis could be a 
secondary effect of ID disorganization. Furthermore, Scn5a downregulation could be 
a secondary consequence of Cx43 alteration in the ID (Moncayo-Arlandi & Brugada, 
2017). On the other hand, there are evidences of Scn5a loss of function in old mice 
leading to fibrosis and reduced expression of Cx43 (van Veen et al, 2005). Thus, 
determining which is the cause and which the consequence would need further 
analyses.  
As mentioned above, Meis1 genetic variants have been associated with PR interval 
elongation in humans (Pfeufer et al, 2010; Smith et al, 2011b; Butler et al, 2012a). 
However, we did not detect any alterations on this interval upon double inducible 
deletion of Meis1 and Meis2 in CMs. This is likely due to the low efficiency of 
recombination of α-MHC-MerCreMer in atria, although the association found in 
humans does not tell about the type of alteration in Meis1 function (gain or loss 
function) that drives the phenotype. Nonetheless, Meis1 and Meis2 loss of function in 
adult ventricular CMs also leads to decreased expression of Hcn4 and Cntn2, which 
are markers of the CCS, suggesting a specific function of Meis in CCS cardiomyocytes. 
We consider idKOs might have alterations in the VCS, although we have not been able 
to find any functional impairment specifically in these cells. We are currently studying 
the Cntn2 expression pattern in the Purkinje Fiber network in this model and the 
consequences of Meis1 and Meis2 double specific deletion in CCS, using a Hcn4-
CreERT knockin line.  
The molecular changes found by RNA-seq data in idKO ventricles indicate certain 
similarities between Meis loss of function and those observed in mouse models of 
ARVC. A murine model developed by Dr. Delmar (Cerrone et al, 2012a) consisting on 
Pkp2 (desmosome structural protein) deletion in adult CMs recapitulates some 
features of human ARVC. In Pkp2 conditional KO mice there is desmosome 
disorganization that leads to decreased levels of expression of many other proteins 
important for the intercalated discs, such us Cx43. The pathology starts with interstitial 
fibrosis that can affect only the right or both ventricles, and with time evolves to dilated 
cardiomyopathy, impaired cardiac function and death. Moreover, intracellular calcium 
homeostasis is affected due to downregulation of key regulatory genes like RyR2 and 
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Cacna1c. Comparing RNA-seq data from Meis1 and Meis2 idKO and Pkp2 inducible 
KO, we found that key genes for the ARVC phenotype where commonly affected in 
both models. Furthermore, PKP2 deletion leads to significant downregulation of Meis1 
and Meis2 genes. Thus, we propose that Meis TFs could be partly under the control of 
the regulatory network involved in the ARVC-like phenotype present in Pkp2 mutant 
hearts (Cerrone et al, 2012a). To further study this possibility, we are currently 
developing a mouse line with simultaneous Pkp2 deletion and Meis2 overexpression 
in adult CMs. We will determine whether Meis2 can rescue aspects of the ARVC 
phenotype in this mouse model. 
In humans, ARVC also leads to ventricular arrhythmias and sudden death (Zhao et al, 
2019). In the murine model of Pkp2 deletion, arrhythmias only appeared upon acute 
isoproterenol treatment. However, Meis1 and Meis2 idKO mice did not preferentially 
show arrhythmic episodes after the same treatment. We hypothesized that Meis1 and 
Meis2 inducible deletion in adult CMs recapitulates some features of ARVC but this is 
not enough to reproduce the complete phenotype found in Pkp2 inducible KOs. 
Actually, in the volcano plot in FIG. 34B it can be observed that Pkp2 deletion leads to 
many more gene expression changes than those observed in Meis mutants. 
PUTATIVE DIRECT TARGETS OF MEIS 
In the last part of this thesis project, we examined the putative direct targets of Meis1 
and Meis2 in cardiomyocytes. Comparing the three RNA-seq performed in developing 
atria and ventricles and adult ventricles from Control and idKO hearts, we found 28 
genes differentially expressed in the three conditions. Gene ontology analysis related 
16 of those genes with several biological functions: heart development and contraction, 
regulation of transport and secretion. Despite the fact that 28 genes are a low input for 
a gene ontology analysis, the categories found are closely related to the phenotypes 
described upon Meis loss of function, which suggests this gene list is relevant to the 
mechanisms involved in the phenotypic alterations. Furthermore, Fhl2 and Lrrc10, 
which are strongly downregulated, have been previously as hypertrophic growth 
repressor (Okamoto et al, 2013) and cardiac excitation-contraction coupling regulator, 
respectively (Chiamvimonvat & Song, 2018). By contrast, nothing has been reported 
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before about EfnB3 expression or function in the heart, despite of being one of the 
most downregulated in Meis mutants. We are currently working on the expression 
pattern of this protein.  
Analysis of previous Meis ChIP-seq data from the lab, performed in E10.5 embryos 
and E11.5 embryonic trunk (Longobardi et al, 2014; Delgado I et al, unpublished), 
revealed putative Meis binding sites among the genes of interest. As we have 
explained before, Cacna1c could be playing a central role in the development of 
arrhythmias, together with Gja1 downregulation. However, our results only detected 
possible Meis direct regulation in Cacna1c and not Gja1. Nppa, which appears 
upregulated in all conditions, does not seem to be a direct target of Meis. This result 
fits with the role of Nppa as a general responder to a wide variety of cardiac stresses. 
Interestingly, we also found Clic4 and Gpc1 as potential targets of Meis. Clic4 is 
expressed in the sarcoplasmic reticulum and has been proposed to regulate ryanodine-
receptors (Ponnalagu et al, 2016). Gpc1 is an extracellular matrix protein whose 
expression appeared altered in a model of induce arrhythmias in rat (Vakhitova et al). 
PAM and Prps2 also presented putative binding sites for Meis. PAM is important for 
Nppa secretion in the atria (Eipper et al, 1988; Czyzyk et al, 2005) and Prps2 is 
implicated in the synthesis of purines and pyrimidines and it has been related to cancer 
(Mannava et al, 2008), but nothing is reported about its function in the heart. Using the 
same approach we also identified Meis binding sites in Scn5a and Wnt11 whose 
downregulation might underlie important features of the Meis mutant phenotypes. 
Nevertheless, these results are not enough to determine whether Meis is directly 
regulating those genes or whether Meis is actually binding to some of the genes where 
we did not detect peaks, and further studies specific for cardiomyocytes are needed.  
Overall, we propose that Meis1 and Meis2 TFs play an important role in the regulation 
of calcium and sodium transport and gap junction establishment in developing and 
adult CMs through regulation of Cacna1c, Scn5a and Gja1 expression. The 
downregulation of Cacna1c and Scn5a upon Meis deletion would impair electrico-
mechanical coupling and the intercalated disc structure which could lead to Cx43 
downregulation. These defects result in slower ventricular depolarization. Moreover, 
ID disorganization and CM uncoupling might induce mechanical stress leading to cell 
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death, interstitial fibrosis and mild-hypertrophy, to preserve cardiac function. In the 
formation of the atria, these alterations in cell-cell coupling, together with misregulation 
of cell polarity due to decreased expression of Wnt11 and Wnt5a, are probably 
contributing to the atrial malformations found in dKO embryonic hearts. These 
alterations lead to an increased susceptibility to suffer arrhythmias in newborns, while 
in the adult heart it seems that more factors are needed for arrhythmia manifestation. 
 
 Figure 40. Summary of defects and gene expression changes found in CMs 
lacking Meis1 and Meis2.  In blue are represented genes and processes which are 
impaired upon Meis loss of function in CMs and in red, processed that increase. Blue 
lines link to potential direct targets of Meis and dashed lines to targets with no 
evidence of direct regulat ion. The orange box includes the defects found in mutant 
hearts. 
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CONCLUSIONS 
1) Meis1 and Meis2 transcription factors are expressed in developing and adult 
cardiomyocytes and are necessary for perinatal survival and adult heart homeostasis. 
 
2) The simultaneous deletion of Meis1 and Meis2 deletion in developing cardiomyocytes 
leads to cardiac malformations in atria and ventricles and slower ventricular conduction 
velocity. 
 
3) Fetuses with Meis1 and Meis2 cardiomyocyte-specific loss of function show higher 
frequency of stress-induced arrhythmias than Control littermates. 
 
4) Deletion of Meis1 and Meis2 in adult cardiomyocytes produces interstitial fibrosis and 
QRS enlargement, suggesting a slower propagation of the electrical impulse in 
ventricles. 
 
5) Meis1 and Meis2 deletion in adult cardiomyocytes stimulates endoreplicative DNA 
synthesis preferentially in mononucleated cells but does not stimulate cardiomyocyte 
proliferation. 
 
6) The expression of genes encoding calcium signaling factors, sodium channels and 
Gap-junction proteins are regulated by Meis1 and Meis2 transcription factors in 
cardiomyocytes. 
 
7) Cacna1c, Scn5a, Clic4, Gpc1, Wnt11, PAM and Prps2 are identified as putative direct 
targets of Meis1 and Meis2 in developing and adult cardiomyocytes.  
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CONCLUSIONES 
1) Los factores de transcripción Meis1 y Meis2 se expresan en cardiomiocitos durante el 
desarrollo embrionario y en el corazón adulto y son necesarios para la supervivencia 
de los fetos al nacer y para mantener la homeostasis del corazón adulto. 
 
2) La deleción simultánea de Meis1 y Meis2 en cardiomiocitos durante el desarrollo 
cardiaco conlleva la aparición de malformaciones en las aurículas y los ventrículos, 
además de ralentizar la velocidad de conducción en los ventrículos. 
 
3) Los fetos con falta de función de Meis1 y Meis2 en cardiomiocitos presentan una 
mayor frecuencia de arritmias cuando se exponen a situaciones de estrés. 
 
4) La doble deleción de Meis1 y Meis2 en cardiomiocitos adultos produce fibrosis 
intersticial y un alargamiento del complejo QRS, lo que sugiere que la propagación del 
impulso eléctrico es más lenta. 
 
5) La falta de función de Meis1 y Meis2 en cardiomiocitos incrementa la proporción de 
endoreplicación de ADN preferencialmente en células mononucleadas, pero no 
incrementa la proliferación de los cardiomiocitos. 
 
6) Genes que codifican factores implicados en la señalización del calcio en 
cardiomiocitos, en el establecimiento de las uniones GAP y el transporte del sodio, 
están regulados por los factores de transcripción Meis1 y Meis2. 
 
7) Cacna1c, Scn5a, Clic4, Gpc1, Wnt11, PAM y Prps2 se identifican como posibles 
dianas directas de Meis1 y Meis2 en cardiomiocitos, lo que ayudaría a explicar gran 
parte de los fenotipos descritos.  
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